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TIIVISTELMÄ
Tämä tutkimus on osa Kansanterveyslaitoksen Mielenterveyden ja Alkoholitutkimuksen
osaston ja Helsingin ja Uudenmaan sairaanhoitopiirin Jorvin sairaalan psykiatrian yksi-
kön kaksissuuntaisen mielialahäiriön etenevää seurantatutkimusta (Jorvi Bipolar Study).
Tutkimuksessa on seurattu kaksisuuntaista mielialahäiriötä sairastavia psykiatrisen eri-
koissairaanhoidon avo- ja sairaalapotilaita, joilla tutkimukseen otettaessa oli diagnosoita-
vissa meneillä oleva sairausjakso. Tutkimuksen tavoitteena oli tutkia itsetuhoisen käyt-
täytymisen esiintyvyyttä, itsemurhayritysten ilmaantuvuutta sekä itsemurhayritysten ris-
kitekijöitä tässä potilasryhmässä.
Tutkimusta varten seulottiin 1630, iältään 18-59-vuotiasta potilasta käyttäen Mood
Disorder Questionnaire (MDQ)-mielialahäiriökyselyä. Kyselyn perusteella positiivisiksi
osoittautuneet 490 potilasta haastateltiin puoli-strukturoidulla haastattelumenetelmällä
[the Structured Clinical Interview for DSM-IV Disorders, research version with psychotic
screen (SCID-I/P)]. Tutkimukseen valikoitui lopulta 191 potilasta. Näillä oli diagnosoita-
vissa meneillään oleva kaksisuuntaisen mielialahäiriön sairausjakso, josta myöhemmin
käytetään nimeä indeksijakso.
Potilaat haastateltiin uudestaan 6 ja 18 kuukauden kuluttua. Itsetuhoista käyttäytymistä
tutkittiin sekä indeksijakson että seurannan aikana itsemurha-ajatuksia kartoittavan astei-
kon avulla ja haastattelukysymyksin. Tietoja kerättiin myös sairauskertomuksista. Tieto
erilaisista sairausjaksoista seurannan aikana koottiin yksityiskohtaiseksi graafiseksi ku-
vaajaksi (life-chart).
Tässä tutkimuksessa ilmeni, että itsetuhoinen käyttäytyminen on erittäin yleistä kaksi-
suuntaista mielialahäiriötä sairastavilla potilailla. Indeksijakson aikana 20 % potilaista
yritti itsemurhaa ja itsemurha-ajatuksia esiintyi 61 %:llä. Masennus, toivottomuus, saman-
aikainen muu psykiatrinen sairastavuus ja aikaisempi itsemurhayritys osoittautuivat kes-
keisiksi riskitekijöiksi itsetuhoiselle käyttäytymiselle indeksijakson aikana. Itsetuhoisen
käyttäytymisen esiintyvyys kaksisuuntaisen mielialahäiriön päätyyppien, tyyppi I:n ja II:n,
välillä oli samanlaista.
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Indeksijakson aikana tehdyt itsemurhayritykset sijoittuivat sairauden masennus- ja seka-
muotoisiin vaiheisiin. Itsemurha-ajatuksia esiintyi eniten sekamuotoisten jaksojen aikana.
Toivottomuus ennusti itsemurhayrityksiä masennusjakson aikana. Sekamuotoisen vai-
heen aikana itsearvioitu masennuksen syvyys ja alhaisempi ikä olivat itsemurhayritysten
itsenäisiä riskitekijöitä.
18 kuukauden seurannan aikana 20 % potilaista yritti itsemurhaa. Aikaisemmat itsemur-
hayritykset, toivottomuus, masennusjakso tutkimukseen ottohetkellä ja alhaisempi ikä
ennustivat itsemurhayrityksiä seuranta-aikana. Potilaista 55 % oli yrittänyt itsemurhaa jo-
ko ennen tutkimukseen ottoa, tai yritti sitä indeksijakson tai seurannan aikana.
Seuranta-aikana itsemurhayritysten ilmaantuvuus oli 37-kertainen sekamuotoisen jakson ja
18-kertainen masennusjakson aikana verrattuna muihin jaksoihin. Aikaisempi itsemurhayri-
tys sekä masennus- tai sekamuotoisessa jaksossa vietetty aika ennustivat itsemurhayritystä
seuranta-aikana.
Tutkimus osoittaa kaksisuuntaisesta mielialahäiriöstä kärsivien potilaiden olevan huo-
mattavan itsetuhoaltis ryhmä: yli puolet potilaista on yrittänyt itsemurhaa. Kliinisesti on
erittäin tärkeää tunnistaa kaksisuuntainen mielialahäiriö ja hoitaa sekamuotoiset jaksot ja
masennusjaksot mahdollisimman nopeasti ja tehokkaasti, koska näihin molempiin liittyy
huomattavan korkea itsemurhayritysten riski.
Avainsanat: kaksisuuntainen mielialahäiriö, itsemurha-ajatukset, itsemurhayritys.
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ABBREVIATIONS
ANOVA                   One-Way Analysis of Variance
APA                     American Psychiatric Association
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BD I                    Bipolar Disorder type I
BD II                   Bipolar Disorder type II
BAI                     Beck Anxiety Inventory
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BHS                     Beck Hopelessness Scale
CANMAT                  Canadian Network for Mood and Anxiety Treatments
CBT                     Cognitive-Behavioural Therapy
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DSM                     Diagnostic and Statistical Manual of Mental Disorders
DSM-IV                  Diagnostic and Statistical Manual of Mental Disorders,
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FDA                     Food and Drug Administration
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SMR                     Standardized Mortality Ratio
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SUPRE                   Suicide Prevention
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1. ABSTRACT
The Jorvi Bipolar Study (JoBS) is a collaborative ongoing bipolar research project between
the Department of Mental Health and Alcohol Research of the National Public Health
Institute, Helsinki, and the Department of Psychiatry, Jorvi Hospital, Helsinki University
Central Hospital (HUCH), Espoo, Finland. The JoBS is a prospective, naturalistic cohort
study of secondary level care psychiatric out-and inpatients with a new episode of
Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) bipolar
disorder (BD).
Altogether, 1630 patients (aged 18-59) years were screened using the Mood Disorder
Questionnaire (MDQ) for a possible new episode of DSM-IV BD. 490 patients were
interviewed with semi-structured interview [the Structured Clinical Interview for DSM-IV
Disorders, research version with Psychotic Screen (SCID-I/P)]. 191 patients with new
episode of DSM-IV BD were included in the bipolar cohort study. Psychiatric comorbidity
was evaluated using semi-structured interviews. At 6- and 18-month follow-up, the
interviews were repeated and life-chart methodology was used to integrate all available
information about nature and duration of all different phases. Suicidal behaviour was
examined both at intake and follow-up by psychometric scale [Scale for Suicidal Ideation
(SSI)], interviewer’s questions and medical and psychiatric records. The aim of this
thesis was to evaluate prevalence of suicidal behaviour and incidence of suicide attempts,
and examine the wide range of risk factors for attempted suicide both, at intake and
follow-up, in representative secondary-level sample of psychiatric in- and outpatients
with BD.
In this study suicidal behaviour was common among psychiatric patients with BD. During the
episode when patients were included into cohort study (index episode), 20% of the patients
had attempted suicide and 61% had suicidal ideation. Severity of depressive episode and
hopelessness were independent risk factors for suicidal ideation, whereas hopelessness,
comorbid personality disorder and previous suicide attempt predicted suicide attempts
during the index episode. There were no differences in prevalence of suicidal behaviour
between bipolar I and II disorder; the risk factors were overlapping but not identical.
14
During the index episode, suicide attempts took place during depressive, mixed and
depressive mixed phases. Furthermore, there were marked differences regarding level of
suicidal ideation during different phases, with the highest levels during the mixed phases
of the illness. Hopelessness was independently associated with suicidal behaviour during
the depressive phase. A subjective rating of severity of depression (Beck Depression
Inventory) and younger age predicted suicide attempts during mixed phases.
During the 18-month follow-up 20% of patients attempted suicide. Previous suicide
attempts, hopelessness, depressive phase at index episode and younger age at intake were
independent risk factors for suicide attempts during follow-up. Taken altogether, 55%
patients attempted suicide before index episode, during index episode or during follow-up.
The incidence of suicide attempts was 37-fold during combined mixed and depressive mixed
states and 18-fold during major depressive phase as compared with other phases. Prior
suicide attempt and time spent in combined mixed phases - mixed and depressive mixed - and
depressive phases independently predicted the suicide attempt during follow-up.
More than half of the patients have attempted suicide during their lifetime, a finding
which highlights the public health importance of suicidal behaviour in bipolar disorder.
Clinically, it is crucial to recognize BD and manage the mixed and depressive phases of
bipolar patients fast and effectively, as time spent in depressive and mixed phases
involves a remarkably high risk of suicide attempts.
Keywords: bipolar disorder, suicidal ideation, suicide attempt.
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3. INTRODUCTION
Bipolar disorder is episodic, lifelong and a clinically severe mood disorder. Bipolar
disorder poses a major public health concern due to high rate of mortality, morbidity,
psychosocial impairment, psychosocial disability, health care costs, higher
unemployment, decreased work productivity and secondary substance abuse (Altshuler et al.,
2002; American Psychiatric Association, 2002; Angst et al., 2002; Coryell et al., 1987;
1993; Goetzel et al., 2003; Judd et al., 2002; 2003a; 2003b; 2005; Shi et al., 2004;
Simon, 2003; Ösby et al., 2001). Rihmer and Angst (2005) have estimated the lifetime
prevalence of bipolar disorder to be from 0.1% to 4.8%. There appear to be relatively few
gender differences in bipolar disorder. The age of onset of bipolar disorder, most
commonly around 20 years of age, is substantially (about 10 years) lower than that of
unipolar depression (Rihmer and Angst, 2005). Bipolar disorder is associated with
increased mortality due to cardiovascular diseases and particularly suicide (Ahrens et
al., 1995; Angst et al., 2002; Ösby et al., 2001).
In the year 2000, approximately one million people died from suicide: a "global" mortality
rate of 16 per 100 000, or one death every 31 seconds. In the last 45 years suicide rates
have increased by 60% worldwide. Suicide is now among the three leading causes of death
among those aged 15-44 years (both sexes) (WHO). Over 90% of suicide victims have a
psychiatric disorder at the time of death (Harris and Barraclough, 1997). Risk for
suicides varies according to type of psychiatric diagnosis. Approximately 60% of all
suicides occur in relation to mood disorders (Mann and Currier, 2005). Other psychiatric
disorders associated with an increased risk of suicide are schizophrenia, alcoholism and
those personality disorders which are associated with impulsivity (Mann and Currier,
2005).
A meta-analysis (Harris and Barraclough, 1997) and two recent nationwide studies from
Scandinavia (Ösby et al., 2001; Høyer et al., 2000) indicate a standardized mortality
ratio of about 20 for BD sufferers. Bipolar disorder (BD) is associated with a significant
risk of attempted suicide (Hawton et al., 2005). It is commonly estimated that 25-50% of
them attempt suicide at least once (Goodwin and Jamison, 1990; Jamison, 2000; Slama et
al., 2004), and 30-75% have suicidal ideation (Suppes et al., 2001; MacKinnon et al.,
2005). A comprehensive view of risk factors related to suicidal behaviour in bipolar
disorder is still emerging. Identifying the predictors of suicidal behaviour is a key for
suicide prevention.
The Jorvi Bipolar Study (JoBS) is a prospective, naturalistic cohort study of 191
secondary-level care psychiatric out- and inpatients with a new episode of DSM-IV BD. In
the JoBS the predictors of chronicity, recurrences, suicidal behaviour as well as work and
functional disability are investigated and the adequacy of treatment evaluated. The
present thesis focuses on suicidal behaviour among bipolar patients followed up for 18
months.
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4. REVIEW OF THE LITERATURE
4.1 Bipolar Disorder
4.1.1 Definition of bipolar disorder
Bipolar disorder, or manic-depressive  illness as it was  previously named, is mental disorder
characterized by recurrent episodes of mania, hypomania, mixed states and depression.
Bipolar disorder is divided to bipolar I and bipolar II disorders. Bipolar I disorder is
characterized by one or more manic or mixed episodes usually accompanied by major
depressive episodes. Bipolar II disorder is characterized by one or more major depressive
episodes and at least by one hypomanic episode. The soft bipolar spectrum includes
cyclothymic depressions (BD-II ), antidepressant-associated hypomania (BD-III),1/2
hyperthymic depressions (BD-IV) and hyperthymic temperament (BD-V) (Akiskal et al.,
2006). Bipolar disorder ranges from a pattern of mild depression and brief hypomania to one
severe rapid cycling or predominant mania with psychotic features (Müller-Oerlinghausen
et al., 2002).
4.1.2 Diagnosis of bipolar disorder
In Finland the tenth edition of the International Classification of Diseases (ICD-10) is
used (WHO, 1993). DSM-IV is frequently used in psychiatric research (American Psychiatric
Association, 2000). A semi-structured interview (SCID) was developed to increase
diagnostic validity and it is based on DSM criteria (First et al., 1997). In this thesis
DSM-IV criteria was used. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
divides mood disorders into the following categories: unipolar depression, bipolar
disorders, mood disorder due to a general medical condition and substance induced mood
disorder.
Major depressive episode is characterized by depressive mood or loss of interest or
pleasure in nearly all activities most of the day for at least two consecutive weeks
(Table 1). The main symptoms are accompanied by changes in appetite or weight, sleep and
psychomotor activity; decreased energy; feelings of worthlessness or guilt; difficulty
thinking, concentrating, or making decisions; or recurrent thoughts of death or suicidal
ideation, plans or attempts. Further, the episode must be accompanied by clinically
significant distress or impairment in social, occupational, or other important areas of
functioning. There are no differences in DSM-IV criteria regarding unipolar depression or
major depressive episode of bipolar disorder.
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Manic episode is characterized by abnormally and persistently elevated, expansive or
irritable mood lasting at least one week (or less if hospitalisation is required) (Table 2).
The mood disturbance is accompanied by inflated self-esteem or grandiosity, decreased
need for sleep, pressure of speech, flights of ideas, distractibility, increased
involvement in goal-directed activities or psychomotor agitation and excessive involvement
in pleasurable activities with a high potential for painful consequences. The disturbance
must be sufficiently severe to cause marked impairment in social, occupational functioning
or to require hospitalisation, or it is characterized by the presence of psychotic
features.
Mixed episode is characterized by a period of lasting at least one week in which the
criteria are met both for a manic episode and for a major depressive episode nearly every
day (Table 3). Further, the disturbance must be sufficiently severe to cause marked
impairment in social, occupational functioning or to require hospitalisation, or it is
characterized by the presence of psychotic features.
Hypomanic episode is characterized by persistently elevated, expansive or irritable mood
lasting at least four days (Table 4). The mood disturbance is accompanied by inflated
self-esteem or grandiosity, decreased need for sleep, pressure of speech, flights of
ideas, distractibility, increased involvement in goal-directed activities or psychomotor
agitation and excessive involvement in pleasurable activities with a high potential for
painful consequences. Hypomanic episode must be clearly different from the individual’s
usual nondepressed mood, and there must be a clear change in functioning that is not
characteristic of the individual’s usual functioning, and changes in mood and functioning
must be observable by others.
Depressive mixed state is characterized by three or more simultaneous intra-episode
hypomanic symptoms present for at least 50% of time during a major depressive episode
(Benazzi and Akiskal, 2001).
Differential diagnosis is important to chart potential hypomanic and manic episodes when
investigating depressive patients, the Mood Disorder Questionnaire (MDQ) (Hirschfeld et
al., 2000) may be a useful tool but is not sufficient without careful diagnostic interview
to make an adequate diagnosis. The pilot study for the Jorvi Bipolar Study found that the
sensitivity of MDQ was relatively high (0.85), but specificity only moderate (0.50).
However, the optimal cut-off within this sample was found to be eight symptoms but
accepting also minor problems due to episodes (sensitivity 0.90, specificity 0.61)
(Isometsä et al., 2003). When an individual aged over 50 years has first manic or
hypomanic episode possibility of organic aetiology of mood episode must be evaluated.
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Table 1. DSM-IV criteria for Major Depressive Episode
A. Five (or more) of following symptoms have been present during the same two week period
   and represent a change from previous functioning; at least one of the symptoms is either
   depressed mood or loss of interest or pleasure:
     (1)  depressed mood most of the day, nearly every day
     (2)  markedly diminished interest or pleasure, in all, or almost all, activities most of the day,
          nearly every day
     (3)  significant  weight loss or gain or decrease or increase in appetite nearly every day
     (4)  insomnia or hypersomnia nearly every day
     (5)  psychomotor agitation or retardation nearly every day (observable by others)
     (6)  fatigue or loss of energy nearly every day
     (7)  feelings of worthlessness or excessive or inappropriate guilt nearly every day
     (8)  diminished ability to think or concentrate, or indecisiveness, nearly every day
     (9)  recurrent thoughts of death, recurrent suicidal ideation without a specific plan
          or a suicide attempt or a specific plan for committing suicide.
B. The symptoms do not meet criteria for a Mixed Episode.
C. The symptoms cause clinically significant distress or impairment in social, occupational or
   other important areas of functioning.
D. The symptoms are not due to the direct physiological effects of a substance (e.g., drug of
   abuse, a medication) or a general medical condition.
E. The symptoms are not better accounted for by bereavement.
Diagnosis of bipolar disorder according diagnostic and statistical manual of mental disorders,
Fourth Edition (DSM-IV), Text Revision (American Psychiatric Association, 2000)
Table 2. DSM-IV criteria for Manic Episode
A. A distinct period of abnormally and persistently elevated, expansive or irritable mood, lasting
   at least one week (or less if hospitalisation is required).
B. During the period of mood disturbance, three (or more) of the following symptoms have
   persisted (four, if the mood is only irritable) and have been present to a significant degree:
     (1)  inflated self-esteem or grandiosity
     (2)  decreased need for sleep
     (3)  more talkative than usual or pressure to keep talking
     (4)  flights of ideas or subjective experience that thoughts are racing
     (5)  distractibility (i.e., attention too easily drawn to unimportant or irrelevant external stimulus)
     (6)  increased involvement in goal-directed activities or psychomotor agitation
     (7)  excessive involvement in pleasurable activities with a high potential for painful consequences.
C. The symptoms do not meet criteria for a Mixed Episode.
D. The disturbance is sufficiently severe to cause marked impairment in occupational
   functioning or in usual social activities or relationships with others, or to necessitate
   hospitalisation to prevent harm to self or others or there are psychotic features.
E. The symptoms are not due to the direct physiological effects of a substance (e.g., drug of
   abuse, a medication) or a general medical condition.
Diagnosis of bipolar disorder according diagnostic and statistical manual of mental disorders,
Fourth Edition (DSM-IV), Text Revision (American Psychiatric Association, 2000)
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Table 3. DSM-IV criteria for Mixed Episode
A. The criteria are met for both a Manic Episode and for a Major Depressive Episode (except duration)
   nearly every day during at least a 1-week period.
B. The mood disturbance is sufficiently severe to cause marked impairment in occupational functioning or
   in usual social activities or relationships with others, or to necessitate hospitalisation to
   prevent harm to self or others or there are psychotic features.
C. The symptoms are not due to the direct physiological effects of a substance (e.g., drug of
   abuse, a medication) or a general medical condition.
Diagnosis of bipolar disorder according diagnostic and statistical manual of mental disorders,
Fourth Edition (DSM-IV), Text Revision (American Psychiatric Association, 2000)
Table 4. DSM-IV criteria for Hypomanic Episode
A. A distinct period of persistently elevated, expansive or irritable mood, lasting throughout at
   least 4 days that is clearly different from the usual nondepressed mood.
B. During the period of mood disturbance, three (or more) of the following symptoms have
   persisted (four, if the mood is only irritable) and have been present to a significant degree:
     (1)  inflated self-esteem or grandiosity
     (2)  decreased need for sleep
     (3)  more talkative than usual or pressure to keep talking
     (4)  flights of ideas or subjective experience that thoughts are racing
     (5)  distractibility (i.e., attention too easily drawn to unimportant or irrelevant external stimulus)
     (6)  increased involvement in goal-directed activities or psychomotor agitation
     (7)  excessive involvement in pleasurable activities with a high potential for painful consequences.
C. The episode is associated with an unequivocal change in functioning that is uncharacteristic
   of the person when not symptomatic.
D. The disturbance in mood and the change in functioning are observable by others.
E. The episode is not severe enough to cause marked impairment in social or occupational
   functioning or to necessitate hospitalisation and there are no psychotic features.
F. The symptoms are not due to the direct physiological effects of a substance (e.g., drug of
   abuse, a medication) or a general medical condition.
Diagnosis of bipolar disorder according diagnostic and statistical manual of mental disorders,
Fourth Edition (DSM-IV), Text Revision (American Psychiatric Association, 2000)
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4.1.3 Epidemiology of bipolar disorder
Lifetime  prevalence  of  bipolar I disorder is often assumed to be about 1%, whereas there is
no reliable estimate of prevalence of bipolar II disorder, mainly because the challenge
for diagnosis of hypomania in general population surveys. However, Rihmer and Angst (2005)
have estimated the lifetime prevalence of bipolar disorder to be from 0.1% to 4.8%. Recent
Finnish general population study, the Psychoses in Finland (PIF), which is based on the
Health 2000 Study, found that lifetime prevalence for bipolar I disorder was 0.24% (Perälä
et al., 2007) (Table 5). Perälä et al. (2007) noticed in their comment that the inclusion
of register diagnosis of BD I disorder for the nonresponse group would lift the prevalence
to 0.42%.
In the National Institute of Mental Health (NIMH) Epidemiological Catchment Area Study
(ECA), the lifetime prevalence rate of bipolar I disorder was 0.8%, and of bipolar II 0.5%
(Rihmer and Angst, 2005; Weissman et al., 1988). The National Comorbidity Survey
Replication (NCS-R) is a nationally representative face-to-face household survey of
English-speaking household residents aged 18 years and older in the United States (N=9282)
conducted between February 2001 and April 2003 using the fully structured World Health
Organization (WHO) World Mental Health (WMH) Survey version of the Composite
International Diagnostic Interview (CIDI) (Kessler et al., 2004). Lifetime prevalence of
DSM-IV/ WMH-CIDI Disorders in Total NCS-R Sample was 3.9 for bipolar disorder (I-II)
(Kessler et al., 2005a) and 12-month prevalence of DSM-IV and WMH-CIDI Disorders was
2.6 for bipolar I and II disorders (Kessler et al., 2005b). In a previous National Comorbidity
Survey (NCS) lifetime prevalence of bipolar I disorder was estimated to be 1.6% and
12-month prevalence only slightly lower (Kessler et al., 1994)
The Netherlands Mental Health Survey and Incidence Study (NEMESIS) is a prospective
survey in the Dutch general population aged 18-64, with three assessment points in 1996,
1997 and 1999. A total of 7076 respondents were interviewed. The lifetime prevalence of
bipolar disorder found in the NEMESIS was 1.9% (ten Have et al., 2002). National
Epidemiologic Survey on Alcohol and Related Conditions (NESARC) found that prevalence
of 12-month and lifetime DSM-IV bipolar I disorder were 2.0% (95% CI=1.82 to 2.18) and
3.3% (95% CI=2.76 to 3.84) (Grant et al., 2005). Community studies conducted in European
countries found 12-month prevalence of bipolar disorder range from 0.2% to 1.1% (Wittchen
and Jacobi, 2005; Pini et al., 2005).
An Australian general population survey study reported 12-month prevalence for bipolar
disorder to be 0.5% (Mitchell et al., 2004). In recent Chinese study according the
lifetime prevalence of DSM-IV/WMH-CIDI Disorders study found 0.1% lifetime prevalence
for bipolar disorder (I-II) (Lee et al., 2006). The Zurich cohort study (22-35 years young
adults) identified a 5.5% prevalence of DSM-IV hypomania/mania and a further 2.8% for
brief hypomania (recurrent and lasting 1-3 days) (Angst, 1998).
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In the Finnish study which was based on the Finnish Hospital Discharge Register from 1987
to 1994, Räsänen et al. (1998) reported the annual rate of all hospitalized patients with
bipolar disorder was 0.03%. In their conclusions, they hypothesized the low prevalence and
incidence of bipolar disorder in Finland may be due to late onset-age. Sorvaniemi and
Salokangas (2005) reported the 1-month and 12-month prevalence of BD were 0.9% and 2.1%
respectively. In community mental health centres, the corresponding figures were 4.4% and
7.6% (Sorvaniemi and Salokangas, 2005). Kieseppä et al. (2004) estimated the annual
incidence of bipolar disorder I was 5.8/100 000 (95% CI=5.4 to 6.3).
Delays of diagnosis of bipolar disorder
Bipolar disorder is often misdiagnosed. First, there is a long delay before a correct
diagnosis is made. Second, there are patients who switch to bipolar disorder from unipolar
disorder just during follow-up. In a survey of bipolar members of the United States
National Depressive and Manic-Depressive Association, a third (34%) of respondents had
had more than 10 years of treatment before receiving a bipolar diagnosis and 69% were
misdiagnosed, with the most frequent misdiagnosis being unipolar depression (Hirschfeld et
al., 2003). Mantere et al. (2004) reported that in Jorvi Bipolar Study (JoBS) 25.6% of
bipolar I patients and 50.5% of bipolar II were previously undiagnosed. Respectively,
Baldessarini et al. (1999) reported that the time from illness onset to maintenance
treatment takes on average 8 years (7 years for type I, 10 years for type II syndromes).
Furthermore, bipolar disorder begins often with depressive episode and thus cannot be
diagnosed as bipolar disorder before first mixed, manic or hypomanic episode.
Table 5. Prevalence of bipolar disorder
Lifetime prevalence of bipolar disorder (I and II)
NCS-R         3.9  %       Kessler et al., 2005a   United States       N=9282
Lifetime prevalence of bipolar I disorder
NCS           1.6  %       Kessler et al., 1997    United States       N=8098
NEMESIS 1.9  %       ten Have et al., 2002   Netherlands         N=7076
NESARC 3.3  %       Grant et al., 2005      United States       N=43093
PIF           0.2  %       Perälä et al., 2007     Finland             N=8028
12-month prevalence of bipolar disorder (I and II)
NCS-R         2.6  %       Kessler et al., 2005b   United States       N=9282
12-month prevalence of bipolar I disorder
NESARC 2.0  %       Grant et al., 2005      United States       N=43093
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Switching from unipolar to bipolar disorder
Angst and colleagues (2005) reported that a diagnostic change from depression to bipolar I
occurred in about 1% of the patients per year and to bipolar II disorders in about 0.5%
per year. In their over an average of 20 years follow-up a diagnostic change from
depression to bipolar disorder occurred in 39.2% of cases (121/309), in 75 of them (24.3%)
changing to BD-I and in 46 (14.9%) changing to BD-II (Angst et al., 2005). Risk factors
for a change from depression to BD-I were male gender and an early onset of the disorder;
risk factors for a change from depression to BD-II were female gender, a later onset of
the disorder and a positive family history of mania (Angst et al., 2005). Goldenberg et
al. (2001a) reported in a 15-year follow-up that 27% of the study group (N=74) had
developed one or more distinct periods of hypomania, while another 19% had at least one
episode of full bipolar I mania. In the Finnish Vantaa Depression Study (VDS) the 18-month
follow-up 13 of unipolar depressed patients 269 (5%) switched to bipolar disorder
(Melartin et al., 2004).
4.1.4 Aetiology and pathogenesis of bipolar disorder
The aetiology of bipolar disorder is multifactorial and poorly known. Bipolar disorder is
probably determined by multiple genetic loci and environmental influences also play an
important role in it’s development (Taylor et al., 2002; Smoller and Finn, 2003).
Independent of familial loading, life events increase the liability to mood disorders in
children of patients with bipolar disorder but the effects slowly diminish with time
(Hillegers et al., 2004).
Heritability
Bipolar disorder is highly heritable (McGuffin et al., 2003). Family, twin and adoption
studies have been essential in defining the genetic epidemiology of bipolar disorder
(Hayden and Nurnberger, 2006; Smoller and Finn, 2003; Taylor et al., 2002). Kieseppä et
al. (2004) demonstrated the high heritability of bipolar disorder in a nationwide
population-based twin sample assessed with structured personal interviews. The model of
genetic and specific environmental variance was the best-fitting model, with a
heritability estimate of 0.93 (Kieseppä et al., 2004). Family studies have documented that
first-degree relatives of affected individuals have an excess risk of the disorder, while
twin studies (and to a lesser extent, adoption studies) suggest that genes are largely
responsible for this familial aggregation (Smoller and Finn, 2003). Taylor et al. (2002)
report in their review that family studies have shown the approximate lifetime risk of a
first-degree relative of a bipolar proband to be 5% to 10%. Moreover, studies of
monozygotic twins show that their risk of contracting the disease is as much as 75 times
greater than that for the general population. In addition, adoption studies have
demonstrated that biological relatives of bipolar patients are substantially more likely
to have the disorder than are adoptive relatives (Taylor et al., 2002).
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Structural brain imaging
Neuroimaging studies can be divided into structural studies and functional brain imaging
studies. Computed tomography (CT) and magnetic resonance imaging (MRI) are used in
structural studies. Several recent neuroimaging studies of mood disorders have concluded
that bipolar disorder is associated with structural brain changes, but their results have
been inconsistent (McDonald et al., 2004). The recent meta-analysis by McDonald et al.
(2004) of regional morphometric MRI studies was based on 26 studies comprising volumetric
measurements on up to 404 independent patients with bipolar disorder. The authors reported
that patients with bipolar disorder had enlargement of the right lateral ventricle, but no
other regional volumetric deviations which reached significance (McDonald et al., 2004).
Strong heterogeneity existed for several regions, including the third ventricle, left
subgenual prefrontal cortex, bilateral amygdala and thalamus (McDonald et al., 2004).
White matter hyperintensities are relatively non-specific lesions reported to occur with
increased frequency in BD, although this is a matter of debate (Sublette et al., 2006). It
has been hypothesized that white matter hyperintensities may produce mood disorders by
interrupting relevant brain pathways (Soares and Mann, 1997). Furthermore, there is
growing awareness of the effect of white matter hyperintensities on neuropsychological
functioning (Singh et al., 2005).
Functional brain imaging
Positron emission tomography (PET), single-photon emission computed tomography (SPECT)
and, more recently, functional magnetic resonance imaging (fMRI), provide methods for
defining the anatomy of brain function. These technologies can be used to produce brain
maps that correspond to changes in brain metabolism or blood flow (representing brain
’activation’), which are obtained at rest or during cognitive tasks designed to study
specific neural networks (Strakowski et al., 2005). Functional imaging studies report
activation differences between bipolar and healthy controls in anterior limbic regions
(Strakowski et al., 2005).
Neurochemistry
There is considerable evidence that dopamine and noradrenalin system abnormalities are
present in bipolar disorder (Singh et al., 2005; Manji et al., 2003). Furthermore,
evidence from neuroimaging post-mortem and genetic studies suggests that bipolar disorder
is associated with abnormalities of the serotonin transporter (5-HTT) system (Cannon et
al., 2006; Ichimiya et al., 2002; Mann et al., 2000). The direction of abnormality in the
brainstem was opposite to that found in the cortex, thalamus, and striatum. Elevated 5-HTT
binding in the cortex may be related to anxiety symptoms and syndromes associated with BD
(Cannon et al., 2006). Also, cholinergic system abnormalities are present in bipolar
disorder (Manji et al., 2003). More recently, research into the pathophysiology and
treatment of mood disorders has moved from a focus on neurotransmitters and cell surface
receptors to intracellular signalling cascades (Manji et al., 2003). Conceptual and
experimental evidence suggests that abnormalities in the regulation of signal transduction
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cascades and neuroplasticity could, more primarily than abnormalities monoamine
neurotransmitter systems, underlie the pathophysiology of BD (Manji et al., 2003).
Magnetic resonance spectroscopy investigations have also revealed abnormalities of
membrane and second messenger metabolism (Strakowski et al., 2005).
Neuroendocrinology
The hypothalamus integrates disparate information about the milieu and is the primary
coordinator of mass-sustained organismic functions (e.g., circadian rhythms, appetite and
motivational states, which may be experience as mood) (Seidman, 2005). The hormone axes
are critical components of hypothalamic-regulated homeostatic adaptation (Seidman, 2005).
Activation of the hypothalamic-pituitary-adrenal (HPA) axis modulates cognitive
processes, pain and sleep (Seidman, 2005). Stress is primarily mediated by HPA axis (Singh
et al., 2005). One prevailing etiological theory in BD proposes abnormalities of an
interactive system, whereby hypothalamic releasing factors trigger pituitary production of
adrenocorticotropic hormone, stimulating the adrenal gland to produce corticosteroids that
provide feedback to the brain (Sublette et al., 2006).
4.1.5 Course and outcome of bipolar disorder
Longitudinal course of bipolar disorder is chronic and dominated by depressive features of
disorder and affective symptoms below the threshold of major depressive episode and mania
(Judd et al., 2002; 2003a; 2003b; Post et al., 2003; Perlis et al., 2006; Mantere et al.,
in press). Relapse is usually defined as a return of a mood episode after a period of
less than 2 months with symptoms below the mood episode threshold. Recurrence is usually
defined as emergence of symptoms sufficiently severe to satisfy criteria for a new mood
episode after at least 2 consecutive months of partial or full remission.
In the Stanley Foundation Bipolar Network Study, a prospective follow up, over half of
patients (62.8%) had 4 or more episodes/year and nearly third of patients (30.6%) had more
than 8 episodes/year (Post et al., 2003). In the multicentre Systematic Treatment
Enhancement Program for Bipolar Disorder (STEP-BD) study during up to 2 years of
follow-up, nearly half of patients (48.5%) experienced recurrences; the majority of
recurrences (70%) were to the depressive pole, with a ratio of 2.5:1 for depressive
recurrence versus manic/mixed/hypomanic episodes (Perlis et al., 2006). Recurrence was
frequent and associated with the presence of residual mood symptoms at initial recovery
(Perlis et al., 2006). In the McLean-Harvard First-Episode Mania Study within 2 years of
syndromal recovery, 40% experienced a new episode of mania (20%) or depression (20%) and
19% switched phases without recovery (Tohen et al., 2003). Syndromic recovery was defined
by Tohen et al. (2003) as patient no longer met DSM criteria for a manic, mixed, or
depressive syndrome. Predictors of mania recurrence were initial mood-congruent psychosis,
lower premorbid occupational status and initial manic presentation. Predictors of
depression onset were higher occupational status, initial mixed presentation and any
comorbidity (Tohen et al., 2003).
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In the National Institute of Mental Health (NIMH) Collaborative Depression Study, a mean
of 13.4 years of prospective follow-up, depressive symptoms dominated the course of
bipolar II disorder; patients experienced approximately 39 times more depressive symptoms
(50.3% of all follow-up weeks) than hypomanic symptoms (1.3% of all follow-up weeks) and
patients were symptomatic 53.9% of all follow-up weeks (Judd et al., 2003a). In their
analogous study regarding bipolar I patients they found that patients were symptomatically
ill 47.3% of weeks throughout a mean of 12.8 years of follow-up (Judd et al., 2002).
Symptom severity and psychosocial disability fluctuate together during the course of
illness (Judd et al., 2005; Altshuler et al., 2002). Each increase or decrease in
depressive symptom severity is associated with a highly significant stepwise increase or
decrease in psychosocial disability (Judd et al., 2005). Likewise, patients with BD-I show
a similar pattern of significant stepwise change in impairment as their level of manic
symptom severity changes between mild subsyndromal symptoms and hypomania or between
hypomania and mania (Judd et al., 2005).
Recent review reported that predictors of episodes of bipolar disorder include stressful
life events, increased number of previous episodes, decreased interval between episodes
and persistence of affective symptoms and episodes. Factors associated with longer
survival times include psychotherapy, social support and medication adherence (Altman et
al., 2006). A growing body of evidence suggests that bipolar patients exhibit
neuropsychological impairment that persists even during the euthymic state, which may be a
contributory factor to a poor psychosocial outcome (Robinson and Ferrier, 2006). The
weight of evidence suggests that greater neuropsychological dysfunction in bipolar
disorder is associated with a worse prior course of illness, particularly the number of
manic episodes, hospitalisations and length of illness (Robinson and Ferrier, 2006).
4.1.6 Comorbidity of bipolar disorder
The majority of patients with bipolar disorder, of all ages and both genders, have at
least one comorbid psychiatric or medical disorder and many have more than one (Krishnan,
2005). Axis I comorbidity is associated with severity of illness, earlier age at onset,
rapid cycling, family history of alcoholism, drug abuse and suicidal behaviour (McIntyre
et al., 2006; Nolen et al., 2004; Frye et al., 2003; McElroy et al., 2001). Somatic
comorbidity is also correlated with several indicators of poorer prognosis and outcome
e.g. longer duration and higher severity of depression (measured by HAM-D) in bipolar I
disorder (Thomson et al., 2006).
In the Stanley Foundation Bipolar Network Study 65% of the patients met DSM-IV criteria
for at least one lifetime comorbid disorder, and 33% met criteria for at least one current
comorbid disorder; 24% patients had three or more lifetime disorders (McElroy et al.,
2001). McElroy et al. (2001) found that 42% of patents met criteria for a comorbid anxiety
disorder, 42% for comorbid substance use disorder and 5% for an eating disorder. Bipolar
disorder is associated with high prevalence of alcohol and substance abuse or dependence.
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Chengappa et al. (2000) reported 57.8% subjects with bipolar I disorder abused, or were
dependent on one or more substances or alcohol, and Frye et al. (2003) found 38% of
patients met the criteria for a lifetime history of alcoholism and the National Institute
of Mental Health (NIMH) Epidemiologic Catchment Area Study (ECA) found that over 60%
of patients with bipolar I disorder developed a substance use disorder during their lifetime.
On the basis of The National Hospital Discharge Register in Finland, Sorvaniemi and
Hintikka (2005) studied the recorded prevalence of psychiatric comorbidity among bipolar
inpatients by clinicians and the associated factors. Of the 2687 hospital stays in 1998,
82% had no other recorded psychiatric diagnosis except an episode of bipolar disorder.
Psychiatric comorbidity was recorded in 18% of hospital stays, of which 20% had two
comorbid psychiatric diagnoses. Substance-related disorders (11%) were the most commonly
recorded comorbid disorders. Personality disorders were recorded in 6%, and anxiety
disorder in 1% of the hospital stays (Sorvaniemi and Hintikka, 2005). Studies based on
discharge register records indicate that comorbidity disorders of BD are under recognized
in clinical task. Mantere et al. (2006) have also reported high rates of comorbidity
related to BD based on Structured Clinical Interview for DSM-IV Disorders (both Axis I and
II). Of the patients, 70% had a current comorbid disorder; on Axis I 60%, Axis II 43%.
Anxiety disorders were prevalent in 45%, substance use disorders in 20% and eating
disorders 8% (Mantere et al., 2006).
4.1.7 Treatment of bipolar disorder
The goals of treatment of bipolar disorder are the treatment of acute phase and prevention
of future episodes. Treatment of bipolar disorder should always consist of pharmacotherapy
and psychosocial interventions. Pharmacotherapy of bipolar disorder is usually divided to
acute phase treatment and maintenance treatment. Following recommendations of
pharmacotherapy are based on Canadian Network for Mood and Anxiety Treatments
(CANMAT) guidelines for management of patients with bipolar disorder and it’s update in
2007 (Yatham et al., 2005; 2006), National Institute for Health and Clinical Excellence
(NICE) clinical guideline (2006): The management of bipolar disorder in adults, children
and adolescents in primary and secondary care, The World Federation of Societies of
Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar
disorders, part III: maintenance treatment (Grunze et al., 2004) and American Psychiatric
Association: Practice guideline for the treatment of patients with Bipolar disorder (APA,
2002). Response, regarding pharmacotherapy, means that the patient has experienced at
least a 50% reduction in symptoms as assessed on a standard psychiatric rating scale, for
instance, Hamilton Depression Rating Scale. Remission is used when no DSM symptoms are
present and the patient is actually well.
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4.1.7.1 Pharmacotherapy
Acute phase pharmacotherapy 
Manic episode
Lithium, divalproex sodium, atypical antipsychotics are recommended as a first-line acute
pharmacological treatment of manic episode. Lithium is superior to placebo and comparable
in efficacy to conventional antipsychotics and anticonvulsant agents, with response
occurring in about 50-70% of patients. Lithium has also been shown to be as effective as
the atypical antipsychotics, olanzapine, risperidone and quetiapine, and the conventional
antipsychotic, haloperidol. In a meta-analysis, the efficacy of divalproex was superior
to placebo and equivalent to lithium and carbamazepine in the treatment of mania.
Clinically, divalproex sodium is preferred because it has fewer gastrointestinal side
effects compared with divalproex and valproic acid. In two studies examining the efficacy
of divalproex compared with olanzapine in acute mania, one showed similar efficacy while
the other showed statistically the significant superiority of olanzapine. A pooled
analysis comparing an oral loading of divalproex to lithium or olanzapine showed no
differences in early efficacy between these agents. Atypical antipsychotic monotherapy
with olanzapine, risperidone, quetiapine, ziprasidone and aripiprazole are also
recommended for the first-line treatment of acute mania.
The combinations of lithium or divalproex with various atypical antipsychotics
(risperidone, quetiapine or olanzapine) have demonstrated significant beneficial effects
compared with lithium or divalproex monotherapy. If therapy with one of the first-line
agents (lithium, divalproex or an atypical antipsychotic) at optimal doses is inadequate
or not tolerated, the next step should involve switching to or adding-on an alternate
first-line agent. In patients who are inadequately responsive to first-line agents,
second-line choices would include other anticonvulsants such as carbamazepine and
oxcarbazepine, the combination of lithium plus divalproex or electroconvulsive therapy
(ECT). If a patient is taking an antidepressant at the onset of an acute manic episode,
the antidepressant should be stopped. Benzodiazepines are recommended as adjunctive therapy
rather than as primary antimanic agents. Monotherapy with gabapentin, topiramate,
lamotrigine, verapamil, tiagabine, risperidone and carbamazepine are not recommended for
the treatment of acute mania.
Mixed episode 
The simultaneous presentation of manic and depressive symptoms presents significant
treatment challenges. Lithium is not as effective in mixed states as it is in classic
mania, while divalproex appears to be equally effective in both mixed episodes and pure
mania. Atypical antipsychotics alone or in combination with lithium or divalproex have
shown conflicting results, but for the most part appear to be as effective in patients
with mixed episodes as in those with classic mania. Conventional antipsychotics are not
recommended for treatment of mixed states. Antidepressants also are not recommended during
mixed states.
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Depressive episode
Lithium remains a recommended first-line therapy for acute bipolar depression with
response rates ranging from 64% to 100%. Long-term lithium treatment is associated with
reduced risk of suicide and suicide attempts among bipolar disorder patients (Baldessarini
et al., 2003; 2006a; Tondo et al., 2000; 2003; Cipriani et al., 2005; Müller-Oerlinghausen
et al., 2005; Kessing et al., 2005). Thus, lithium is indicated for depressive and suicidal
BD patients. Antidepressants may be useful as adjunctive therapy for bipolar depressed
patients who cannot tolerate high serum lithium levels, or who have depressive symptoms
that are refractory to lithium. Lamotrigine and quetiapine monotherapy are also
recommended as a first-line therapy for depressive episode. Olanzapine plus Selective
Serotonin Reuptake Inhibitors (SSRI) and lithium or divalproex plus SSRI/bupropion
continue to remain the other first-line options by the update of CANMAT 2007.
Antidepressants should be avoided for patients with depressive episode who have rapid
cycling. Gabapentin is not recommended for treatment of depressive episode.
Maintenance treatment 
Maintenance treatment has multiple goals: prevent relapses, reduction of subthreshold
symptoms, reduction of suicide risk and reduction of cycling frequency and mood
instability as well as improvement of functioning (American Psychiatric Association,
2002). Four medications have been approved by the United States Food and Drug
Administration (FDA) for maintenance treatment of bipolar disorder: lithium, lamotrigine,
olanzapine and aripiprazole. All these medications have been studied as long-term relapse
prevention monotherapy in bipolar disorder (Keck, 2006). However, lamotrigine has not been
recommended as a single, first-line agent in bipolar I disorder, but only for patients
with mild manias.
4.1.7.2 Psychosocial interventions
Various forms of psychosocial intervention have been found efficacious as adjunctive
treatments for bipolar disorder. These include Family-Focused Therapy (FFT), Interpersonal
and Social Rhythm Therapy (IPSRT), Cognitive-Behavioural Therapy (CBT) and individual or
group psychotherapy (Miklowitz et al., 2000; Miklowitz, 2006; Colom et al., 2003; Lam et
al., 2005; Frank et al., 2005).
The psychosocial interventions usually have same common features (Keck, 2006). Firstly,
they emphasize the need for medication, education about medication and adherence.
Secondly, they emphasize detection of early warning signs for recurrence. Thirdly, they
stress the importance of helping patients cope with and anticipate stressors that trigger
mood episodes. Fourthly, it is considered important to identify and treat comorbid
illnesses (Keck, 2006). Interpersonal therapy with a social rhythm component IPSRT may
also help promote periods of euthymia in bipolar patients (Frank et al., 2005).
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Patients with bipolar I disorder suffering from frequent relapses were randomly assigned
into a cognitive therapy plus medication group or a controlled condition of medication
only (Lam et al., 2005). Patients in the cognitive therapy group had significantly fewer
days in bipolar episodes after the effect of medication compliance was controlled. The
results showed that cognitive therapy had no significant effect in relapse reduction over
the last 18 months of the study period (Lam et al., 2005). In disagreement, Scott et al.
(2003) compared the effectiveness of treatment as usual with Cognitive Behavioural
Therapy. They found that more than half of the patients had a recurrence by 18 months and
they found no significant differences between these two groups (Scott et al., 2003).
Patients assigned to FFT plus mood stabilizing medication had fewer relapses and longer
delays before relapses during the study year, compared with intervention involving two
family education sessions and follow-up crisis management plus mood stabilizing
medication. Patients in FFT also showed greater improvements in depressive (but not manic)
symptoms (Micklowitz et al., 2000).
Yet cognitive behavioural psychotherapies and psychoeducational approaches do not appear
to be frequently or systematically employed in clinical practice, and this may contribute
to the considerable residual morbidity and mortality associated with conventional
treatment (Post and Leverich, 2006). As Miklowitz and Taylor (2006) report there is a need
for randomized clinical trials of Family-Focused Therapy, or other adjunctive psychosocial
interventions, to investigate the effectiveness of these treatments to reduce suicidal
behaviour of bipolar patients.
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4.2 Suicidal behaviour
The concept of suicidal behaviour ranges from suicidal ideation to suicide attempts and
completed suicide (Table 6). Suicidal behaviour may vary with respect to manifestation,
performance, seriousness and lethality. Suicidal behaviour is characterized with a variety
of terminology in the literature. The American Psychiatric Association’s (APA) definitions
of terms were used in this thesis (APA, 2003).
4.2.1 Classification of suicidal behaviours
Table 6. Classification of suicidal behaviour by Beck (1986)
I.   Suicide Ideation  
     Thinking, planning
     Impulse or desire
     A. Intent to die (High, medium, low, none)
II.  Suicide attempt  
     A. Intent
     B. Lethality
     C. Method
III. Completed suicide    
     A. Intent
     B. Method
4.2.2 Risk factors of suicidal behaviour and stress-diathesis model
Suicidal behaviour is a result of the interaction between psychological, social and biological
factors (van Heeringen et al., 2000). Nongenetic familial factors that may contribute to
risk of suicidal behaviour include the effect of parenting, sexual and physical abuse.
Suicidal behaviour is the result of the triggering of psychobiological defeat scripts as a
consequence of the perception of uncontrollable rejection or loss. It is highlighted by
the fact that the environment appears to exert its influence even in the antenatal,
perinatal and early postnatal periods, and thus affects our ability to deal with stressors
at a later age (van Heeringen et al., 2000).
There is clear evidence that the activity of three neurobiological systems have a role in
the pathophysiology of suicidal behaviour. This includes (van Heeringen, 2003; Mann,
2003): hyperactivity of the hypothalamo-pituitary-adrenal (HPA) axis, dysfunction
of the serotonergic (5-HTTergic) system and excessive activity of the noradrenergic
system. Hyperactivity of the hypothalamo-pituitary-adrenal axis and high activity of the
noradrenergic system appear to be involved in the response to stressful events (van
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Heeringen, 2003). Dysfunction of the serotonergic system is thought to be trait-dependent
and associated with disturbances in the regulation of anxiety, impulsivity and aggression
(van Heeringen, 2003; Mann and Currier, 2005). Postmortem studies of suicide victims have
revealed decreased serotonin activity in the ventrolateral prefrontal cortex (Mann et al.,
1999). Prefrontal localized hypofunction and impaired serotonergic responsivity are
proportional to the lethality of the suicide attempt and may mediate the effects of
suicide intent and impulsivity on lethality (Mann, 2003). There is disagreement regarding
a possible link between plasma polyunsaturated fatty acid status and suicidal behaviour
(Sublette et al., 2006; Hakkarainen et al., 2004).
A number of psychological variables have been found associated with suicidal behaviour:
impulsivity, dichotomous thinking (tendency to think in terms of all or nothing),
cognitive rigidity, hopelessness, problem-solving deficits, over-general autobiographic
memory (tendency to remember events in a summarized and over-general way) and biases in
future judgement (Beck, 1986; Williams and Pollock, 2000). Freud proposed that most
individuals cope with the loss of a loved person through the experience of mourning.
However, he believed there are other certain vulnerable individuals for whom the loss
experience is unbearable and generates enormous anger. The individual feels ambivalence
but preserves the mental image of the loved person by internalization and it becomes part
of the ego. Feelings of anger towards the lost object are not possible to express and so
they are transformed into self-censure and the wish to harm oneself. When these feelings
reach a critical pitch they lead to the urge to destroy the self (Williams and Pollock,
2000).
Hopelessness is a key psychological variable of suicidal behaviour (Beck et al., 1986;
1989; 1990). Hopelessness can be a state or trait-related variable (Mann et al., 1999).
Hopelessness has proven to be a better predictor of suicidal intent than depression, and
is believed to mediate the association between depression and suicidal behaviour (Beck,
1986). Hopelessness, or the absence of rescue factors such as positive expectancies,
thereby may also occur independent of depression, or apparent excess of degree of
depression. Whether hopelessness leads to suicidal behaviour depends upon the presence or
absence of risk and protective factors. However, little is known about factors that
protect against the development or occurrence of hopelessness in depressed individuals
(van Heeringen et al., 2000).
Stress-diathesis model
Mann and colleagues (1999) have proposed a stress-diathesis model to explain the
relationship between the risk factors affecting the threshold for suicidal behaviour and
the precipitants that trigger it. This model understands the diathesis as a predisposition
to suicidal behaviour in individuals. That is, a set of enduring conditions or traits
constitutes a diathesis, the presence of which makes an individual more likely to engage
in suicidal behaviour when encountering a stressor, than someone without the diathesis
(Mann et al., 1999). Thus, aggressive and impulsive traits and tendency to pessimism (more
suicidal ideation, hopelessness, subjective depression, a perception of fewer reasons for
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living) are two elements of the diathesis (Mann et al., 1999). Among the many types of
stressors, the onset or acute worsening of psychiatric disorder is nearly always present
in suicide attempters (Mann and Currier, 2005). Furthermore, Mann and colleagues (1999)
suggest that a patient must have at least one major risk factor from each domain (stressor
and diathesis) to be at high risk for suicide.
4.2.3 Suicidal ideation
4.2.3.1 Definition of suicidal ideation 
Suicide ideators are commonly defined as individuals who have thoughts and wishes of
suicide, but have not made any overt suicide attempt (Beck, 1986). Suicidal ideation
includes suicide threats, suicidal preoccupations and expressions of the wish to die as
well as indirect indicators of suicide planning. Suicidal ideation appears be an important
marker for identifying patients at risk for suicide (Brown et al., 2000) and suicide
attempts (Mann et al., 1999). In a 20-year prospective study of risk factors for suicide
in psychiatric outpatients, Brown and his co-workers found patients who scored three or
higher on the Scale for Suicidal Ideation (SSI) were approximately seven times more likely
to commit suicide than patients who scored less than three (Brown et al., 2000).
4.2.3.2 Epidemiology of suicidal ideation
Weissman et al. (1999) reported that the lifetime prevalence of suicidal ideation varies
from 2% to 18%, whereas Bertolote et al. (2005) found that the rate for suicidal ideation
varies from 2.6% to 25.4% in the general population. Kessler et al. (2005c) reported no
statistically significant differences between the National Comorbidity Survey (NCS) and
the National Comorbidity Survey Replication (NCS-R) in the 12-month prevalence of suicidal
ideation (2.8% vs. 3.3%), suicide plans (0.7% vs. 1.0%) or suicide gestures (suicide
attempt without intention) (0.3% vs. 0.2%). Suicidal ideation can be measured by one item
of Beck Depression Inventory (BDI) or Scale for Suicidal Ideation (SSI). Furthermore,
suicidal ideation can be charted during a different time period. These factors explain the
differences of epidemiology of suicidal ideation
The Outcome of Depression International Network (ODIN) study involves five countries in
Europe (N=12 000). Adults aged between 18 and 64 were selected from the general population
and screened for possible depressive disorder using the Beck Depression Inventory (BDI).
As a part of this study Casey et al. (2006) recently found suicidal ideation to be
reported at 7.4% in Norway, 2.3% in Spain, 7.4% in Wales, 9.8% in Finland and 14.6% in
Ireland based on detailed analysis of item 9 of the BDI, which measured the severity of
suicidal ideation.
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The European Study on the Epidemiology of Mental Disorders (ESEMED) is a cross-sectional
household survey carried out in six European countries (Belgium, France, Germany, Italy,
the Netherlands and Spain). In this study 21,425 respondents (aged 18 years or older) were
interviewed between January 2001 and August 2003. Lifetime prevalence of suicidal ideation
was 7.8% (Bernal et al., 2006).
The Finnish 12-month follow-up study of suicidal ideation, Hintikka et al. (2001),
reported that the 12-month incidence was (4.6%) and prevalence of suicidal ideation
(14.7%) in the general population. Suicidal ideation was higher in men than in women (9.2%
and 3.1%, respectively). Sixty-nine per cent of those men and 59 % of those women who had
suicidal ideation at baseline continued to have suicidal thoughts on follow-up (Hintikka
et al., 2001).
4.2.3.3 Risk factors of suicidal ideation
Studies of nonfatal suicidal behaviour have focused mainly on risk factors for suicide
attempts and only few studies focused on suicidal ideation. Suicidal ideation can appear
at any time in life, and most individuals who report suicidal ideation will never attempt
suicide (Bernal et al., 2006). The risk for suicidal ideation is increased by depression
(Casey et al., 2006; Hintikka et al., 2001), but decreased by being older (age ≥30 years),
being married, having someone who is concerned for you and having people to count on
(Casey et al., 2006). In NCS and NCS-R surveys suicidal ideation was related to younger
age, being female and low level of education (Kessler et al., 2005c).
Sokero et al. (2003) reported hopelessness, alcohol dependence or abuse, low level of
social and occupational functioning and poor received social support to be significant
independent risk factors for suicidal ideation among psychiatric in- and outpatients with
DSM-IV major depressive disorder. Sokero et al. (2006) have also reported that a decline
in suicidal ideation among patients with major depressive disorder is predicted by a
preceding decline in hopelessness and depressive symptoms.
4.2.4 Suicide attempt
4.2.4.1 Definition of suicide attempt 
Suicide attempt is defined as a self-injurious behaviour with a nonfatal outcome
accompanied by evidence (either explicit or implicit) that the person intended to die
(APA, 2003). Suicide attempts vary in both lethality and suicidal intent (Mann and
Currier, 2005). A suicide attempt may or may not result in injures (O’Carroll et al.,
1996). An aborted suicide attempt refers to an event in which an individual is one step
away from attempting suicide, but does not complete the act, and thus incurs no physical
injury (APA, 2003; Barber et al., 1998). By definition, an aborted suicide attempt had to
involve at least some degree of intent to die, a change of mind immediately before the
actual attempt and the absence of injury. Suicidal intent is defined as subjective
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expectation and desire for a self-destructive act to end in death (APA, 2003). Lethality of
suicidal behaviour is objective danger to life associated with a suicide method or
action (APA, 2003).
Deliberate self-harm is defined as wilful self-inflicting of painful, destructive or
injurious acts without intent to die (APA, 2003). This term is used in the United Kingdom
for all episodes of survived self-harming behaviours regardless of intent (Skegg, 2005).
In North America this term refers to episodes of bodily harm without suicidal intent,
especially if the behaviour is repetitive (Skegg, 2005). Furthermore, in North America
this term usually excludes overdoses and methods of high lethality (Skegg, 2005).
Parasuicide is used in the World Health Organization (WHO) /European study on parasuicide
and this term includes all suicide attempts. WHO’s definition of parasuicide is the
following: "an act with nonfatal outcome, in which an individual deliberately initiates a
nonhabitual behaviour that, without intervention by others, will cause self-harm, or
ingests a substance in excess of the prescribed or generally recognized therapeutic
dosage, and which is aimed at realizing changes which he/she desired via the actual or
expected physical consequences" (World Health Organization, 1986). Simple alcohol
intoxication is not regarded as parasuicide.
4.2.4.2 Epidemiology of suicide attempt
Official statistics on suicide attempts are not usually collected annually, as in the case
of completed suicides. However, there are several epidemiologic surveys. The World Health
Organization Suicide Prevention-Multisite Intervention Study on Suicide (WHO/SUPRE-
MISS) investigates suicidal behaviours in a number of nations. Bertolote et al. (2005)
reported that prevalence of suicide attempts varies from 0.4% to 4.2%. Kessler et al.
(2005c) reported there were no significant changes that occurred between 1990-1992 and
2001-2003 in the 12-month prevalence of suicide attempts in the general population (0.4%
vs. 0.6%).
The World Health Organization/EURO Multicentre Project on Parasuicide included sixteen
centres in 13 European countries. The highest average male age-standardized rate of
suicide attempts was found in Helsinki, Finland (314/100,000), and the lowest rate
(45/100,000) was for Guipuzcoa, Spain, representing a 7-fold difference. The highest
average female age-standardized rate was found for Cergy-Pontoise, France (462/100,000)
and the lowest (69/100,000) again for Guipuzcoa, Spain. With only one exception
(Helsinki), the person-based suicide attempt rates were higher among women than men. In
the majority of centres, the highest person-based rates were found in the younger age
groups. More than 50% of the suicide attempters made more than one attempt, and nearly 20%
of the second attempts were made within 12 months after the first attempt (Schmidtke et
al., 1996).
In a sample of the Finnish general population (N=4868), the self-reported prevalence of
parasuicide was 0.9% in women and 1.1% in men (Hintikka et al., 1998).
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4.2.4.3 Risk factors of suicide attempt
Kessler et al. (1999) reported that based on the National Comorbidity Survey (NCS) the
risk factors of a suicide attempt were significantly related to being female, being
previously married (divorced or widowed), being born in a recent cohort (year of birth
1966-1975) and having a low educational level. In replication survey, younger age and
being previously married were associated with suicide attempts. Females as compared to
males had consistently higher rates for suicide attempts in most countries in National
Institute of Mental Health (NIMH) Epidemiological Catchment Area Study (ECA) (Weissman
et al., 1999).
It has been reported that more than 90 % of suicide attempters have suffered from mental
disorders (Suominen et al., 1996; Beautrais et al., 1996; Haw et al., 2001; Hawton et al.,
2003a). In both surveys, NCS and NCS-R, nearly 90% of suicide attempters met criteria for
one or more of the 12-month DSM disorder (Kessler et al., 2005c). Major depression was
the most common individual disorder among people with suicide-related behaviours in both
surveys, whereas anxiety disorders were the most common class of disorders (Kessler et
al., 2005c). Suominen et al. (1996) reported that at least one Axis I diagnosis was made
in 98% of suicide attempters. Depressive syndromes were more common among females,
whereas alcohol dependence was more common among males (Suominen et al., 1996).
Suominen et al. (2000) found suicide attempters with personality disorders more often had a
history of previous suicide attempts and lifetime psychiatric treatment than comparison
subjects. However, suicide attempts did not differ in terms of suicide intent, hopelessness,
lethality or impulsiveness between subjects with or without personality disorders.
Past suicidal behaviour is a strong indicator of future suicide attempts (Borges et al.,
2006; Zahl and Hawton, 2004). A mortality follow-up study was conducted on 11 583 people
who presented themselves to the general hospital in Oxford in the UK between 1978 and 1997
(Hawton et al., 2003b). Of the cohort, 10.2% persons had died by the end of 2000 and 2.6%
of the cohort had died by suicide or probable suicide. The most frequent method of suicide
was self-poisoning, with little difference between the genders in the distribution of this
and other methods of suicide. The majority, however, had used a method different from that
used in the index episode of self-harm (Hawton et al., 2003b). A follow-up of this cohort
study was conducted to examine risk of death from a range of causes during a follow-up
period of between 3 and 23 years (Hawton et al., 2006). The number of deaths (1,185,
10.2%) was 2.2 times the expected number, the excess being significantly greater in males
than females (Hawton et al., 2006).
Sokero et al. (2003) reported that severity of depression and current alcohol dependence
or abuse in particular, but also younger age and low level of social and occupational
functioning independently predicted suicide attempts among psychiatric in- and outpatients
with DSM-IV major depressive disorder.
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4.2.5 Suicide
4.2.5.1 Definition of suicide
Suicide is defined as a self-inflicted death with evidence (either explicit or implicit)
that the person intended to die (APA, 2003). This term should be utilized only in the case
of death.
4.2.5.2 Epidemiology of suicide
Global suicide rates per 100 000 population have been estimated and published since 1950.
There is great variation between countries regarding death rates of suicide (Schmidtke,
1997; WHO). Suicide rates are usually higher in male than in female for all age-groups. In
Finland the suicide rate is among the highest in Europe (17.9/100 000 in 2005). For
example, in Sweden, the suicide rate is 13.2 /100 000 in 2002 and in Hungary 27.7/100 000
in 2003 (WHO).
4.2.5.3 Risk factors of suicide
Repetition is one of the core characteristics of suicidal behaviour. Among those who
commit suicide, up to 37% have attempted suicide previously (Harris and Barraclough,
1997). A suicide attempt is the strongest known predictor for completed suicide (Nordström
et al., 1995; Harris and Barraclough, 1997; Möller, 2003; Owens et al., 2005). Owens et
al. (2002) reported suicide risk among self-harm patients is hundreds of times higher than
in the general population. Isometsä and Lönnqvist (1998) reported 56% of suicide victims
were found to have died at their first suicide attempt, thus even if a suicide attempt is
a powerful single predictor of completed suicide, it’s sensitivity as a risk factor is
limited.
The psychological autopsy method offers the most direct technique currently available for
examining the relationship between particular antecedents and suicide (Cavanagh et al.,
2003). The review of psychological autopsy studies indicated that mental disorder was the
most strongly associated variable of those that have been studied with suicide (Cavanagh
et al., 2003). Likewise, Arsenault-Lapierre et al. (2004) reported in their meta-analysis
that on average 87% of the subjects who committed suicide had a mental disorder.
Approximately 60% of all suicides occur in relation to mood disorders (Mann and Currier,
2005). Other psychiatric disorders associated with increased risk of suicide include
schizophrenia, alcoholism and personality disorders (Mann and Currier, 2005). Furthermore,
Harris and Barraclough (1997) calculated a Standardized Mortality Ratio (SMR) for each
psychiatric disorder. In their conclusion they write that virtually all mental disorders
have an increased risk of suicide excepting mental retardation and dementia (Harris and
Barraclough, 1997).
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Hopelessness   is   a   key   psychological   factor   in   suicidal   behaviour   (Beck,  1986).
Hopelessness is associated with completed suicide in many studies (Fawcett et al., 1987;
1990; Beck et al., 1989; 1990; Keller and Wolfersdorf, 1993; Nordentoft et al., 1993).
Hopelessness is defined as a state of negative expectations (Beck et al., 1974). In a
20-year prospective study of risk factors for suicide in psychiatric outpatients, Brown
and his co-workers (2000) found patients who scored a nine or above on the Beck
Hopelessness Scale (BHS) (Beck et al., 1974) were approximately four times more likely
than patients who scored eight or below to commit suicide within a given year of
follow-up. Beck et al. (1985) reported of hospitalised patients because of suicidal
ideation, the Hopelessness Scale and the pessimism item of the Beck Depression Inventory
predicted the eventual suicides. A score of 10 or more on the Beck Hopelessness Scale
correctly identified 91% of the eventual suicides (Beck et al., 1985). Hopelessness is
usually measured by the Beck Hopelessness Scale (BHS) which consists of 20 true-false
statements that assess the extent of negative expectancies about the future. The possible
range of scores is from 0 to 20 (Beck et al., 1974). Suicide attempters’ reaction to
survival is also found to be a risk factor for eventual suicide (Henriques et al., 2005).
The time period after discharge from a psychiatric hospital is known to be a high risk
time for completed suicide for up to one year (Kapur et al., 2006; Qin and Nordentoft,
2005; Pirkola et al., 2005; Ho, 2003; Goldacre et al., 1993). In a Danish population-based
nested case-control study based on register data, unemployment, low income, being single
and a history of mental illness necessitating hospital admission, were associated with
increased risk of suicide. However, in the multivariate analysis, the strongest risk
factor was mental illness necessitating hospital admission; risk of suicide was especially
high during admission (relative risk 62.6) and during the year after discharge
(6.51)(Mortensen et al., 2000).
In a Finnish study, Suokas and Lönnqvist (1991) investigated self-poisoned patients who
were treated in the emergency room of Helsinki University Central Hospital. By the end of
a 5-year follow-up period, 3.2% of these had committed suicide. Risk factors were being
male of advancing age, having mental disorders, previous suicide attempts, a nonimpulsive
index suicide attempt, moderate to very serious lethality and severe intention to die
during the index suicide attempt (Suokas and Lönnqvist, 1991).
In a Finnish study concerning patients who attempted suicide and who were treated in
general hospitals, Suominen et al. (2004a) reported 8% of attempters committed suicide
during the 12-year follow-up. The only statistically significant risk factor for eventual
suicide was high scores on the Beck Suicidal Intention Scale (Suominen et al., 2004a).
Furthermore, suicides continued to accumulate almost four decades after suicide attempt
(Suominen et al., 2004b).
Pirkola et al. (2005) reported the register-based study collected in a comprehensive
dataset covering all suicides in Finland during 1980-2001. On the basis of the available
information on previously hospitalized victims, they found that subjects committing
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suicide soon after discharge from hospital treatment for psychiatric disorders differed
from later suicides of previously hospitalised patients; in more often being female,
having more often received treatment for a schizophrenia spectrum or affective disorder
and less often for a substance-related disorder. They had more often used suicide methods
of easier availability (particularly drowning and jumping from heights), had more often
been an employee and had more often had a higher grade of education (Pirkola et al.,
2005).
4.2.6 Prevention of suicidal behaviour
In 1999 WHO launched Suicide Prevention (SUPRE), it’s worldwide initiative for prevention
of suicide. The overall objectives of the SUPRE project are to reduce mortality and
morbidity due to suicidal behaviours, to break the taboo surrounding suicide and to bring
together national authorities and the public in an integrated manner to overcome the
challenges.
Specific objectives are: To bring about a lasting reduction in the number of suicides and
suicide attempts, with emphasis on developing countries and countries in social and
economic transition. To identify, assess and eliminate at early stages, as far as
possible, factors that may result in young people taking their own lives. To raise the
general awareness about suicide and provide psychosocial support to people with suicidal
thoughts or experiences of attempted suicide, and to their relatives and close friends, as
well as to those of people who committed suicide.
Mann et al. (2005) recently reviewed suicide prevention strategies. They found that
physician education in depression recognition and treatment, and restriction of access to
lethal methods (particularly firearms) reduced suicide rates. Other methods including
public education, screening programs and media education needed more evidence of efficacy.
Furthermore, Mann and Currier (2005) have suggested that in formulating a treatment and
management strategies for suicidal patients, three principal aspects require attention:
diagnosis and treatment of existing psychiatric disorder, assessment of suicide risk and
removal of the means for suicide, specific treatment to reduce the diathesis or propensity
to attempt suicide.
The Finnish Department of Mental Health and Alcohol Research of the National Public Health
Institute has been active in both development of suicide preventive strategies in Finland
and suicide research (Lönnqvist et al., 1995). The national suicide prevention project in
Finland was carried out from 1986 to1996 and consisted of a research phase from 1986 to
1991, an implementation phase from 1992 to 1996 and an internal evaluation phase from 1997
to 1998. The Finnish suicide rate increased during the first years of the project,
followed by a reduction of 20% between 1991 and 1996 and finally dropping to 9% below the
initial level (Upanne et al., 1999; Lehtinen and Taipale, 2001).
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Educational intervention for non-psychiatrically trained multidisciplinary staff to assess
suicide risk and manage suicidal patients was carried out in England (Morriss et al.,
1999). Suicide risk assessment and management skills such as problem solving, future
coping and provision of immediate support were significantly improved after 1 month of
training (Morriss et al., 1999). However, the suicide rate did not change before or after
educational intervention. It seems that brief educational interventions to improve the
assessment and management of suicide for front-line health professionals in contact with
suicidal patients, may not be sufficient to reduce the population suicide rate (Morriss et
al., 2005).
A 2-year intervention program was performed in Nuremberg at four levels: training of
family doctors and support through different methods, a public relations campaign
informing about depression, cooperation with community facilitators (teachers, priests,
local media, etc.) and support for self-help activities as well as for high-risk groups
(Hegerl et al., 2006). The effects of the 2-year intervention on the number of suicidal
acts (completed suicides plus suicide attempts) were evaluated. Compared to the control
region (Wuerzburg), a reduction in frequency of suicidal acts and suicide attempts was
observed in Nuremberg during the 2-year intervention. The reduction was most noticeable
for high-risk methods (e.g. hanging, jumping and shooting). Concerning completed suicides,
there were no significant differences compared to the control region (Hegerl et al.,
2006).
4.3 Suicidal behaviour in bipolar disorder
4.3.1 Epidemiology of suicidal behaviour in bipolar disorder
Bipolar disorder (BD) is associated with a significant risk of suicidal behaviour (Hawton
et al., 2005; Baldessarini et al., 2006b). Chen and Dilsaver (1996) found in their study
that patients with bipolar disorder are at higher risk of suicidal behaviour than those
suffering from other Axis I disorders. Bipolar disorder is related with increased
mortality due to cardiovascular diseases and particularly suicide (Ahrens et al., 1995;
Angst et al., 2002; Ösby et al., 2001).
4.3.1.1 Epidemiology of completed suicide
Guze and Robins (1970), who were the first to systematically review the suicide risk of
bipolar disorder (or manic-depressive illness), found that approximately 15% of all
deaths among manic-depressive patients were the result of suicide. Goodwin and Jamison
(1990) reported in their review that approximately 19% of manic-depressive patients died
by suicide. In both of these analyses, bipolar disorder was not consistently discriminated
from major unipolar depression. Furthermore, both studies were based on hospitalised
patients. These two reviews have been criticized by Bostwick and Pankratz (2000) because
both reviews calculated proportionate mortality (the percentage of the dead who died by
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suicide) rather than case fatality (the percentage of the original sample who died by
suicide) and because most of the studies included, in both estimates of lifetime suicide
risk, had follow-up periods of only a few years. Proportionate mortality must provide a
biased estimate of suicide risk because the risk of suicide is not constant across the
history of affective disease (Bostwick and Pankratz, 2000). The risk is highest in the
beginning of the onset of affective disorder and soon after discharge from hospital.
A meta-analysis of studies on suicide risk in all psychiatric disorders, Harris and
Barraclough (1997), found the risk of suicide in bipolar disorder was 15 times the
expected. This meta-analysis is criticized by Rihmer because it reviewed studies which had
not considered bipolar II separately (Rihmer and Kiss, 2002). This overestimates the
suicide risk for unipolar depression and underestimates the same risk for bipolar illness
(Rihmer and Kiss, 2002). Tondo and co-workers (2003) indicate in their meta-analysis that
the standardized mortality ratio to be (observed deaths/expected deaths) about 20 for BD
sufferers. Estimates in samples of never-hospitalized patients with affective disorders
have reported lifetime suicide rates of about 6% (Bostwick and Pankratz, 2000; Inskip et
al., 1998). In one prospective follow-up of 220 bipolar inpatients there was an increased
risk of death by suicide (SMR=12.28) (Angst et al., 2002). It is estimated that prevalence
of completed suicide among bipolar patients ranges from 19% at the high end (Goodwin and
Jamison, 1990) and to 4-6% at the low end (Inskip et al., 1998).
4.3.1.2 Epidemiology of attempted suicide
Retrospective and cross-sectional studies of attempted suicide in bipolar patients show
that 25-50% attempted suicide at least once (Goodwin and Jamison, 1990; Jamison, 2000;
Slama et al., 2004). Suicide attempts in bipolar disorder tend to be of high lethality:
one completed suicide for three attempts in bipolar disorder compared with one completed
suicide in 18 attempts in the general population (Tondo and Baldessarini, 2000). A recent
study Galfalvy et al. (2006) reported the rate of suicide attempts to be 54% for bipolar I
patients and 63% for bipolar II patients. Recent prospective studies from tertiary care
settings have reported the rate of attempted suicide during follow-up to vary from 19% to
3.7% (Galfalvy et al., 2006; Marangell et al., 2006).
4.3.1.3 Epidemiology of suicidal ideation
It is estimated that 30-75% of bipolar patients have suicidal ideation (Stallone et al.,
1980; Bottlender et al., 2000; Suppes et al., 2001; MacKinnon et al., 2005). There are
only a few studies regarding prevalence and risk factors of suicidal ideation among
bipolar patients.
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4.3.2 Risk factors of suicidal behaviour in bipolar disorder
Hawton and colleagues recently made a systematic review of suicide and attempted suicide
in bipolar disorder (Hawton et al., 2005). Studies were selected for inclusion in their
review if they met the following criteria: an international classification of disease, at
least 90% of the subjects were aged 16 years or over, the design of the study was a cohort
study with a minimum follow-up period of one year, a case-control or a cross-sectional
study, an outcome of suicide or attempted suicide was reported, specific risk factors for
suicide or attempted suicide were investigated. They found 55 articles to fulfil these
criteria. The included articles reported on 13 studies of suicide: the results for three
studies for bipolar patients were supplied by author. The systematical review included 23
studies of attempted suicide, of which, only one was a prospective cohort study.
4.3.2.1 Risk factors for completed suicide
Hawton and co-workers (2005) found in their meta-analysis that male gender and history of
attempted suicide and hopelessness at the index episode were associated with suicide.
Marital status or employment was not related to suicide (Hawton et al., 2005). There were
no statistically significant associations of suicide with personal, social or family
history characteristics (Hawton et al., 2005). Completed suicide was not related to
alcohol or drug abuse, rapid cycling, psychotic symptoms or expression of suicidal ideas
(Hawton et al., 2005). Furthermore, suicide risk did not seem to vary according to whether
the individual had a diagnosis of bipolar I or bipolar II disorder (Hawton et al., 2005).
Ösby et al. (2001) found the standardized mortality ratio for suicide was especially high
for younger patients during the first years after the diagnosis. Høyer et al. (2000) found
the risk of suicide was high both immediately after admission and immediately following
discharge. Tsai and colleagues (2002) found in their logistic regression model that those
bipolar I inpatients who have a first-degree family history of suicide, and who have had
more suicide attempts (at least once in seven years of illness), are more likely to commit
suicide (Tsai et al., 2002).
Isometsä and co-workers (1994) examined suicides of persons with bipolar disorder. Most
suicides of persons with bipolar disorder occurred during a major depressive episode
(79%), but in some cases it occurred during a mixed state (11%) or even during or
immediately after remission of psychotic mania (11%) (Isometsä et al., 1994; Isometsä,
2005). Isometsä et al. (1995) have also reported that adverse life events: serious
conflicts with family, substantial financial deterioration, job problems, somatic illness,
residence change are related to suicide among bipolar patients.
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4.3.2.2 Risk factors for attempted suicide
Hawton and co-workers (2005) found in their meta-analysis that attempted suicide was
significantly more common in single individuals. Furthermore, they reported suicide
attempts were associated with a family history of suicide, the earlier onset of bipolar
disorder, admission to hospital resulting from depression, severity of episodes, mixed
affective states at presentation, rapid cycling, comorbid anxiety disorder and alcohol and
drug abuse (Hawton et al., 2005). However, there are only a few studies which have
assessed a wide range of risk factors for attempted suicide.
Previous suicidal behaviour
History of attempted suicide is a strong indicator of a future suicide attempt (Bottlender
et al., 2000; Nordström et al., 1995; Möller, 2003; Fawcett et al., 1990; Oquendo et al.,
2000; 2004; 2006; Leverich et al., 2003; Harris and Barraclough, 1997). Suicidal ideation
appears also to be an important marker for identifying patients at risk for suicide
attempt (Mann, 1999). Bipolar patients with a history of suicide attempt had more severe
suicidal ideation prior to admission (measured by SSI) (Oquendo et al., 2000; Galfalvy et
al., 2006).
Sociodemographic characteristics
Women attempt suicide generally more often in the general population. The majority of
studies have not found an association with suicide attempt and gender among bipolar
patients (Galfalvy et al., 2006; Tondo et al., 1999; Tsai et al., 1999; Lopez et al.,
2001; Dalton et al., 2003; Leverich et al., 2003). Oquendo and co-workers (2000) found
that among hospitalized bipolar I patients men attempted suicide more often than women,
whereas MacKinnon et al. (2003) reported female gender was associated with suicide
attempts. The majority of previous studies have not found an association with suicide
attempt and age (Tondo et al., 1999; Tsai et al., 1999; Oquendo et al., 2000). However,
Galfalvy et al. (2006) recently reported younger age is related to suicide attempt among
depressed bipolar patients.
Previous studies have not found an association between suicide attempt and marital status
among bipolar patients (Galfalvy et al., 2006; Tsai et al., 1999; Lopez et al., 2001;
Oquendo et al., 2000), instead the Stanley Foundation Bipolar Network Study found that
those who attempted suicide were significantly more commonly single individuals (Leverich
et al., 2003). Oquendo et al. (2000) could not find evidence that having children
protected against suicidal behaviour.
The Stanley Foundation Bipolar Network Study found that patients with a history of a
suicide attempt had less college education and less income (below $ 20 000/year) (Leverich
et al., 2003), whereas other studies have not found an association between suicide attempt
and education (Oquendo et al., 2000; Galfalvy et al., 2006). Unemployment is similarly not
associated with suicide attempt among bipolar patients (Tsai et al., 1999).
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The age of onset of BD is associated with suicide attempt among bipolar disorder patients
in many (Tsai et al., 1999; Lopez et al., 2001; Leverich et al., 2003; MacKinnon et al.,
2003; Galfalvy et al., 2006), but not all studies (Oquendo et al., 2000; Dalton et al.,
2003). Of sociodemographic factors, only the earlier onset of BD has independently
predicted suicide attempt (Tsai et al., 1999).
Personal, social and family characteristics
Lifetime levels of aggression have been found to be higher among bipolar suicide
attempters compared with non-attempters, measured by both the Buss-Durkee Scale and the
Brown Goodwin Aggression History Scale (Oquendo et al., 2000; Galfalvy et al., 2006).
However, hospitalized bipolar I attempters did not differ from non-attempters on the
measure of impulsivity, the Barret Impulsive scale (Oquendo et al., 2000), whereas
Galfalvy found baseline attempters manifested more impulsive traits reflected in evaluated
impulsivity scores (Galfalvy et al., 2006).
In recent studies, attempted suicide is associated with a history of early physical abuse,
early sexual abuse and lack of a confidant prior to illness onset (Leverich et al., 2002;
2003; Leverich and Post, 2006; Galfalvy et al., 2006). Early sexual abuse, as well as lack
of a confidant prior to illness onset, remained independent risk factors for attempted
suicide in multinomial statistics in the Stanley Foundation Bipolar Network Study
(Leverich et al., 2003). Tsai and colleagues (1999) also reported that interpersonal
problems and occupational problems predicted suicide attempt in their logistic regression
model.
In the few previous studies, some aspects of family characteristics are associated with
suicide attempt among bipolar patients. Leverich et al. (2003) found that a family history
of substance abuse and a family history of suicide were associated with suicide attempt in
bipolar patients, whereas some studies did not find any statistically significant
association with family history of affective disorder or family history of suicide attempt
(Dalton et al., 2003; Galfalvy et al., 2006). Lopez et al. (2001) reported family history
of affective disorders to predict suicide attempt among bipolar disorder patients in their
multinomial statistics (Lopez et al., 2001). Of personal, social and family
characteristics, early sexual abuse, lack of a confidant prior to illness onset as well as
both interpersonal and occupational problems and family history of affective disorders,
has independently predicted suicide attempt.
Subtype of bipolar disorder
The prevalence of suicide attempt between bipolar I and II disorders is a controversial
issue (Lester, 1993; Vieta et al., 1997; Rihmer and Pestality, 1999). Some studies
(Stallone et al., 1980; Bulik et al., 1990; Tondo et al., 1999; Balazs et al., 2003) have
reported higher rates of suicide attempt for bipolar II disorder, whereas the Stanley
Foundation Bipolar Network Study (Leverich et al., 2003) and some other studies (Endicott
et al., 1985; Coryell et al., 1987; Dalton et al., 2003) found no difference. In theory,
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bipolar II could carry a higher risk if the longitudinal symptomatic course of BD II is
dominated more by the depressive phase of illness (Judd et al., 2003a), implying more time
at risk for suicidal acts. Alternatively, possible differences related to illness
episodes, such as different severity of depression, lability of mood, level of
hopelessness or other characteristics, such as comorbidity, could result in risk
disparities between bipolar I and II.
Hopelessness
Hopelessness, which has been researched widely as a risk factor for suicide attempt in
suicidology in general, has seldom been studied among BD patients. For instance, the
comprehensive meta-analysis by Hawton did not mentioned hopelessness as a risk factor of
attempted suicide. One study involving hospitalised bipolar I patients showed a trend
towards higher levels of hopelessness (Oquendo et al., 2000), whereas in a recent study
the hopelessness was not related to suicide attempts (Galfalvy et al., 2006). Fawcett and
co-workers found in their prospective study of unipolar and bipolar patients that
hopelessness was a risk factor of attempted and completed suicide (Fawcett et al., 1990).
Clinical state
Depressive aspects of illness have been related to suicide attempts: higher number of
prior major depressive episodes (Oquendo et al., 2000; Fagiolini et al., 2004) higher
levels of depression measured by subjective ratings (BDI) or objective ratings (HAM-D)
prior to admission (Oquendo et al., 2000; Fagiolini et al., 2004; Galfalvy et al., 2006),
history of hospitalisation during depressive episodes (Lopez et al., 2001) and current
depressive or mixed episodes (Oquendo et al., 2000; Tondo et al., 1999), whereas psychotic
features have not found to be related to suicide attempts (Lopez et al., 2001). Rapid
cycling is related to suicide attempt in some studies (Dalton et al., 2003; MacKinnon et
al., 2003; 2005), but not in all (Wu and Dunner, 1993; Serretti et al., 2002). Of clinical
characteristics, history of hospitalization during depressive episodes has independently
predicted suicide attempts.
Comorbidity
The Stanley Foundation Bipolar Network Study found suicide attempters to have a greater
mean number of Axis I comorbid disorders (Leverich et al., 2003). Some previous studies
(Simon et al., 2004; 2007; Leverich et al., 2003), but not all (MacKinnon et al., 2003),
have found comorbid anxiety or anxiety symptoms to be related to suicide attempt.
Likewise, comorbid alcohol dependence or abuse is associated with suicide attempts in many
(Tondo et al., 1999; Potash et al., 2000; Goldberg et al., 2001b; Lopez et al., 2001;
Slama et al., 2004), but not all studies (Oquendo et al., 2000; Leverich et al., 2003).
Also, drug dependence/abuse (Dalton et al., 2003, Goldberg et al., 2001b; Tondo et al.,
1999) eating comorbidity (Leverich et al., 2003), personality disorder, according SCID-II
among bipolar I patients (Ucok et al., 1998), and among bipolar II patients (Vieta et al.,
1999), and Axis II comorbidities based on a self-rated questionnaire, (Leverich et al.,
2003) have been associated with suicide attempts.
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Risk factors of attempted suicide based on prospective studies
In the few published prospective studies, risk factors for suicide attempt have included a
history of suicide attempts (Fawcett et al., 1990; Nordström et al., 1995; Oquendo et al.,
2004; Galfalvy et al., 2006; Gonzalez-Pinto et al., 2006; Marangell et al., 2006), higher
number of suicide attempts (Galfalvy et al., 2006), suicidal ideation (Fawcett et al.,
1990; 1995; Oquendo et al., 2004; Galfalvy et al., 2006; Marangell et al., 2006),
subjective rating of depression severity (Oquendo et al., 2004; Galfalvy et al., 2006),
hopelessness (Fawcett et al., 1990; Oquendo et al., 2004), higher rates of illness
recurrence (Gonzalez-Pinto et al., 2006), higher number of previous hospitalisations
(Galfalvy et al., 2006; Gonzalez-Pinto et al., 2006), few reported reasons for living
(Galfalvy et al., 2006), more days spent depressed, anxious, irritable over the past year
(Marangell et al., 2006), rapid cycling (Coryell et al., 2003), comorbid alcohol
dependence or abuse (Fawcett et al., 1990), cigarette smoking (Oquendo et al., 2004),
borderline personality disorder (Galfalvy et al., 2006), younger age (Galfalvy et al.,
2006; Gonzalez-Pinto et al., 2006), being single (Gonzalez-Pinto et al., 2006),
aggression/impulsivity (Oquendo et al., 2004; Galfalvy et al., 2006), less adherence to
lithium treatment (Gonzalez-Pinto et al., 2006) and family history of mood disorder
(Gonzalez-Pinto et al., 2006).
Limitations of previous prospective studies
However, these prospective studies have mostly (Coryell et al., 2003) or exclusively
(Nordström et al., 1995) included inpatients with mixed and often undifferentiated types
of affective disorders (Fawcett et al., 1990; Nordström et al., 1995; Oquendo et al.,
2004), that have had small bipolar sample sizes (<70) (Nordström et al., 1995; Oquendo et
al., 2004; Galfalvy et al., 2006) or are from tertiary care setting (Galfalvy et al.,
2006). Thus, the generalizability of these findings e.g. to bipolar patients in outpatient
settings, remains somewhat unclear.
Findings from multivariate statistics according prospective studies of attempted suicide
Few previous studies, except the studies by Oquendo et al. (2004), Galfalvy et al. (2006)
and Marangell et al. (2006), have assessed the wide range of risk factors for attempted
suicide or used multivariate statistics. Oquendo et al. (2004) found history of suicide
attempts, subjective rating of the severity of depression and cigarette smoking to
independently predict suicide attempt in their prospective study. Further, Galfalvy et al.
(2006) found family history of suicidal acts and comorbid borderline personality disorder
to predict an early attempt, while younger age, high hostility scores, higher number of past
attempts, subjective pessimism as reflected in depression and suicidal ideation and few
reported reasons for living, predicted suicidal acts during the whole period. Marangell et
al. (2006) reported that percent days depressed in past year and history of suicide
attempts independently predicted suicide attempt.
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4.3.2.3 Risk factors for suicidal ideation
Few studies have examined risk factors for suicidal ideation in bipolar patients. Positive
family history for affective disorder, severe depression, psychotic symptoms (Bottlender
et al., 2000), past suicide attempt (Bottlender et al., 2000; Goldberg et al., 1999),
current comorbid anxiety disorders (Simon et al., 2007), comorbid alcohol abuse or
dependence (Goldberg et al., 1999), comorbid personality disorders in bipolar II disorder
(Ucok et al., 1998; Vieta et al., 1999), panic spectrum symptoms in bipolar I disorder
(Frank et al., 2002), any Axis I comorbidity (Vieta et al., 2000; 2001) and earlier age at
onset (Carter et al., 2003) have been associated with suicidal ideation. Two studies
comparing bipolar I and II disorder (Stallone et al., 1980; Vieta et al., 1997) found no
significant differences in suicidal ideation regarding the prevalence of bipolar disorder.
4.3.3 Prevention of suicidal behaviour in bipolar disorder
Long-term lithium treatment is associated with reduced risk of suicide and suicide
attempts among bipolar disorder patients (Baldessarini et al., 2003; 2006a; Tondo et al.,
2000; 2003; Cipriani et al., 2005; Müller-Oerlinghausen et al., 2005; Kessing et al., 2005).
A recent meta-analysis, involving 85 229 person-years of risk-exposure, including both open
label and randomized controlled trails of 31 studies published since 2001, found the
overall risk of suicides and attempt were five times less among lithium-treated subjects
than among those not treated with lithium (Baldessarini et al., 2006a).
Gray and Otto (2001) recommended, in their review of psychosocial approaches to suicide
prevention, the following as standard elements of a suicide prevention program for
patients with bipolar disorder: vigorous treatment of bipolar disorder, over-rehearsal of
help options for times of distress, training in problem-solving skills, cognitive
restructuring of hopelessness-based cognitions, enhancement of reason for living, training
in emotional tolerance/regulation skills.
4.3.4 Summary of previous studies regarding suicidal behaviour in bipolar
disorder
There is a lack of studies regarding prevalence and incidence of suicidal behaviour in BD.
Previous studies have assessed neither aborted suicide attempts, nor suicide attempts
which (despite intent to die) were not communicated to professionals. Moreover, previous
studies have not examined the incidence of suicide attempts, or differences in incidence
during various phases of bipolar disorder.
Many single risk factors for suicidal behaviour have been investigated in previous
cross-sectional and retrospective studies, but a comprehensive view of risk factors
related to suicidal behaviour in bipolar disorder is still emerging. Suicidal behaviour
and the depressive aspects of BD have been consistently associated with suicide attempts
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in previous studies. The findings for instance regarding subtype of BD, alcohol and
substance dependence or abuse, smoking and rapid cycling, by contrast, have been much less
consistent.
Overall, there are only few prospective studies regarding suicidal behaviour in BD. None
of previous studies have investigated time-varying risk factors and included time at risk
estimations when estimating overall suicide risk. Thus, there is a need for prospective
studies to investigate the wide range of risk factors, including both static and
time-varying risk factors, of suicidal behaviour and use of multivariate statistics, which
is needed to differentiate independent risk factors from confounding associations.
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5. AIMS OF STUDY
The aim of this study was to evaluate prevalence of suicidal behaviour (suicidal ideation and
suicide attempt) and incidence of suicide attempts, and examine a wide range of risk
factors for attempted suicide both cross-sectionally and prospectively in a representative
secondary-level sample of psychiatric in- and outpatients with BD.
The specific aims of the study were:
1. To investigate cross-sectionally the prevalence of suicide attempts and suicidal
      ideation in bipolar I and II disorders, and to examine independent risk factors for
      suicide attempts and suicidal ideation in a representative secondary-level sample of
      psychiatric in- and outpatients with BD.
2. To investigate cross-sectionally the differences in prevalence and risk factors for
     suicidal behaviour during different phases of BD.
3. To investigate prospectively the prevalence of suicide attempters, and to examine
     independent predictors for suicide attempts among a representative secondary-level sample
     of psychiatric in- and outpatients with BD.
4. To investigate whether the incidence of attempted suicide is higher during depressive
     and mixed phases than in other phases, and to examine if common risk factors associated
     with suicidal behaviour (comorbid anxiety disorders, comorbid personality disorders,
     comorbid substance dependence/abuse, hopelessness, severity of depression and lifetime
     psychotic features) modify this risk during depressive and mixed phases.
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6. METHODS
6.1 General study design
The Jorvi Bipolar Study (JoBS) is a collaborative bipolar research project between the
Department of Mental Health and Alcohol Research of the National Public Health Institute,
Helsinki, and the Department of Psychiatry, Jorvi Hospital, Helsinki University Central
Hospital (HUCH), Espoo, Finland. The Department of Psychiatry of Jorvi Hospital provides
secondary-care psychiatric services to all citizens of Espoo, Kauniainen and Kirkkonummi
(261,116 inhabitants in 2002). The ethical committee of HUCH approved the study protocol.
6.2 Screening
Using the Mood Disorder Questionnaire (MDQ) (Hirschfeld et al., 2000), the aim was to
identify all in- and outpatients at the Department of Psychiatry at Jorvi Hospital who
currently had a possible new phase of DSM-IV BD from January 1, 2002 to February 28, 2003.
Attending mental health professionals in the department screened every patient aged 18-59
years for seeking treatment, being referred or already receiving care and now showing
signs of deteriorating clinical state. In addition, despite a negative MDQ screen,
patients were included as positive if suspected to have BD due to their clinical diagnosis
of BD or pertinent symptoms (N=28). A clinical diagnosis of ICD-10 schizophrenia was an
exclusion criterion for screening. Based on pilot study (Isometsä et al., 2003), the
response to MDQ item 3 ("problems due to episodes") was ignored. The sampling procedure is
presented in Figure 1. After a positive MDQ-screen, or suspicion of a BD, the patient was
fully informed about the study project and ther written informed consent requested.
Altogether, 1630 patients were screened, of whom 546 were MDQ-positive or suspected
bipolar. Of 546 patients, 49 refused a face-to-face interview, and seven could not be
contacted.
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6.3 Baseline evaluation
6.3.1 Diagnostic measures
In the second phase of sampling, 490 patients were interviewed face-to-face by a
researcher (OM, HV, PA, KS, SL, MP) using the Structured Clinical Interview for DSM-IV
Disorders, research version with psychotic screen (SCID-I/P) (First et al., 2001). Two
hundred and one patients were diagnosed with DSM-IV bipolar disorder and had a current
episode of bipolar disorder. Ten patients refused to participate, leaving 191 patients in
the bipolar cohort study. Inter-rater reliability was assessed via videotaped interviews,
which were blindly assessed by another rater. In order not to reveal the diagnosis made by
the first interviewer, all items were asked and neither hints of inclusion or exclusion,
nor the diagnosis, were allowed on the tape. In the 20 randomly selected videotaped
diagnostic interviews, agreement was found to be complete (κ for bipolar disorder
overall=1.0; also specifically, for bipolar I=1.0 and bipolar II=1.0). The Structured
Clinical Interview for DSM-IV Personality Disorders (SCID-II) (First et al., 1996) was
also used in the JoBS to assess diagnoses on Axis II. Bipolar II depressive mixed states
was defined according to Benazzi and Akiskal (2001): three or more simultaneous
intra-episode hypomanic symptoms present for at least 50% of the time during a major
depressive episode. The soft bipolar spectrum was excluded.
6.3.2 Observer and self-report scales
In the third phase the current symptomatology of the index episode was evaluated using the
following observer scales: Young Mania Rating Scale (YMRS) (Young et al., 1978), 17-item
Hamilton Depression Scale (HAM-D) (Hamilton, 1960), Scale for Suicidal Ideation (SSI)
(Beck et al., 1979), and Social and Occupational Functioning Assessment Scale of DSM-IV
(SOFAS) (Goldman et al., 1992). The self-report scales included the 21-item Beck
Depression Inventory (BDI) (Beck et al., 1961), Beck Anxiety Inventory (BAI) (Beck et al.,
1988), Beck Hopelessness Scale (BHS) (Beck et al.,1974) and Perceived Social Support
Scale-Revised (PSSS-R) (Blumenthal et al., 1987). There was some delay from screening to
estimating symptom scores in the first interview, which especially in cases of short
hypomanias, meant that the patient had often passed the index episode.
6.3.3 Other characteristics
Information on demographic characteristics was gathered, variables for prior illness
history and preceding treatment, using a graphic retrospective life-chart. Age at illness
onset was defined as the time of onset of the first mood episode fulfilling DSM-IV
criteria. Polyphasic episode was defined as an episode consisting of more than one
distinct phase (depressive, hypomanic, manic, mixed or depressive mixed phase). The index
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episode and index phase were defined respectively as the episode or phase respectively
when the patients were included in the study. The majority of bipolar II (50.5%) and many
bipolar I (25.6%) patients were previously undiagnosed; the remainder had a median 7.8
years delay from first episode to diagnosis (Mantere et al., 2004).
Figure 1. Screening of Eligible Bipolar Patients in the Jorvi Bipolar Study 
        Screened with Mood
        Disorder
        Questionnaire
        N = 1630
                                             Refused screening
                                             N = 46
        Scored as positive or                 Screened negative
        a clinical diagnosis                 N = 1038
        of bipolar disorder
        N = 546
                                             Refused face-to-face
                                             SCID-I interview
                                             N = 49
        Completed face-to-                   Could not be
        face SCID-I                          contacted
        interview                            N = 7
        N = 490
                                             Not bipolar
                                             N = 289
        Eligble bipolar
        patients
        N = 201
                                             Refused to participate
                                             or interrupted
                                             N = 10
        Included in JoBS
        N = 191
Mantere et al., Bipolar Disord 2004;6:395-405
(Reprint with permission of Bipolar Disord, Blackwell Publishing)
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6.3.4 Adequate acute-phase pharmacotherapy
Definitions of adequate acute-phase pharmacotherapy were based on published treatment
guidelines (APA, 2002; Grunze et al., 2002; 2003; Goodwin et al., 2003; Sachs et al.,
2000, 2003). Adequate treatments were defined irrespective of dosage, serum concentrations
or duration of treatments: 1. Adequate treatment for bipolar depression was defined as
monotherapy with lithium or lamotrigine, or combinations of lithium, valproate,
carbamazepine or olanzapine with an antidepressant. A combination of lamotrigine with an
antidepressant was interpreted as inadequate in BD I. 2. Adequate treatment for mania was
defined as both monotherapy and combinations of lithium, valproate, carbamazepine,
atypical antipsychotics or haloperidol. The treatment was interpreted as inadequate if
there was an antidepressant. 3. Adequate treatment for hypomania was defined the same as
for mania. 4. Adequate treatment for mixed state was defined the same as for mania except
that treatment was interpreted as inadequate if there was a conventional antipsychotic.
5. Adequate treatment for depressive mixed state was defined the same as for mixed state.
6. Treatment for rapid cycling was defined as adequate if there was lithium, valproate or
carbamazepine. Treatment with lamotrigine was interpreted as adequate for BD II patients,
but the treatment was classified as inadequate if there was an antidepressant.
6.3.5 Evaluation of baseline suicidal behaviour
Suicidal behaviour was examined in several ways. Current suicidal ideation was first
investigated using the Scale for Suicidal Ideation (SSI), a 19-item observer-rated scale
designed to quantify the intensity of current conscious suicide ideation (Beck et al.,
1979). The patient was then asked whether they had ever seriously considered suicide
during the current episode of bipolar disorder. Unless otherwise stated, suicidal ideation
refers to patients who either scored ≥ 6 in the SSI or had seriously considered suicide
during the index episode. In addition, the occurrence of a suicide attempt during the
current episode of bipolar disorder was investigated, based on both the interview and
psychiatric records. Furthermore, the information on lifetime suicidal behaviour was
recorded according to interview and psychiatric records. By definition, a suicide attempt
had to involve at least some degree of intent to die; self-harm with no such intent did
not count.
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6.4 Follow-up procedure
Follow-up
Life-chart methodology (Melartin et al., 2004; Mantere et al., in press) was used to
integrate all available information about the nature and duration of different phases
during the 18-month follow-up. The JoBS initially included 191 patients with DSM-IV
bipolar disorder, 15 (8%) of whom, neither continued in treatment nor participated in the
6-month follow-up. Of the 176 included in the 6-month follow-up, three patients (2%) died
between the 6-month and the 18-month follow-up (two [1%] by suicide), and 10 patients
dropped out. Thus, both life-chart information, and information on suicide attempts, were
obtained from 163 patients at the 18-month follow-up.
Integration of information into a life-chart
After baseline assessments, patients were prospectively followed up with a life-chart. The
outcome was investigated at 6 and 18 months by repeated SCID-I/P (First et al., 2001)
interviews. In addition, all observer and self-report scales were included at both
follow-up assessments. All medical and psychiatric records were available. The duration of
the phases of follow-up were examined by gathering all available data, which were then
integrated into the form of a graphic life-chart based on DSM-IV criteria, analogous to
the life-chart used in the Vantaa Depression Study (Melartin et al., 2004). This was
created after reviewing all the patient information from the follow-up period at the 6-
and 18-month interviews, which typically lasted 2-3 hours. Besides information of symptom
ratings and visits to attending personnel, change points in the psychopathologic states
using probes related to important life-events was also inquired into, in order to improve
the accuracy of the assessment. Time after the baseline interview was divided into ten
different time periods: euthymia, manic, hypomanic, major depressive, mixed, depressive
mixed (according to Benazzi and Akiskal, 2001), cyclothymic, substance induced mood phase,
and depressive and hypomanic symptoms (Mantere et al., in press).
The graphic life-chart used in this study is similar, but not identical, to the
Longitudinal Interval Follow-Up Evaluation (LIFE) or NIMH life-chart methodology used in
the other prospective studies including and reporting on BD types I and II separately
(Judd et al., 2003b; 2003c; Post et al., 2003; Dittman et al., 2002; Nolen et al., 2004;
Joffe et al., 2004). As with the LIFE, change points in the psychopathologic state using
probes related to important events were investigated. Unlike the LIFE, in the interview
the life-chart was made directly comparable with the DSM-IV criteria, and classified the
patients’ follow-up time into periods of 4 DSM-IV phases of BD (major depression, mania,
hypomania, mixed episode) plus depressive mixed states, full remission with no symptoms of
phases and partial remission, when criteria for neither mood episode nor full symptomatic
remission were fulfilled.
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Definitions for time periods of life-chart
An episode was defined according to DSM-IV criteria and could be monophasic or polyphasic.
Thus, a phase here refers to a monophasic episode, or a single phase of a polyphasic
episode, and similarly, an episode to a monophasic or polyphasic episode. A depressive,
manic, or mixed phase was defined as in DSM-IV; a hypomanic phase had a minimum duration
of 2 days (Angst, 1998; Judd et al., 2003a; Akiskal and Benazzi, 2005), substance induced
mood phase was induced by any psychoactive substance. States of subsyndromal symptoms
(including prodromal or residual symptoms) was defined as a state where the patient was
not euthymic and did not fulfill the criteria of a phase; durations of more than 1 week
for hypomanic symptoms, and more than 2 weeks for depressive symptoms and cyclothymia
were required. A state of euthymic mood is used as a state-variable when the duration
of euthymia is more than 2 weeks.
Drop-out analysis
To ensure validity of the results, it is essential to verify that a greater proportion of
suicidal patients did not exist among those who failed to complete the follow-up study
than among those who were followed up, otherwise selective attrition could be expected to
bias the findings and result in underestimates. This can be only estimated by
investigating whether those who dropped out differ from those completing the study, in
terms of their suicidal behaviour during and preceding the index episode at baseline.
First, differences between patients who were (N=176), and who were not (N=15), included in
the 6-month follow-up were analyzed regarding their suicidal behaviour during the index
episode and before the index episode. Patients who were not included in the 6-month
follow-up did not differ from patients who were included, in terms of suicide attempts,
before the index episode (40% [6/15] vs. 45% [79/176]; p=0.9), suicide attempts during the
index episode (33% [5/15] vs. 19% [34/176]; p=0.3) or suicidal ideation (40% [6/15] vs.
40% [71/176]; p=1.0). Second, differences between patients who were (N=163) and who were
not (N=25) included in the 18-month follow-up were analyzed. The three patients who died
were excluded from this drop-out analysis. Those who were not included in the 18-month
follow-up differed from patients who were included in terms of suicide attempts during the
index episode (40% [10/25] vs. 17% [28/163]; χ2=5.7, p=0.02), but not in suicide attempts
before the index episode (44% [11/25] vs. 44% [72/163]; p=1.0), or suicidal ideation
during the index episode (28% [7/25] vs. 42% [69/163]; p=0.3). Third, differences between
patients who completed the 18-month follow-up study (N=163) vs. who were included in the
6- but not the 18-month follow-up (N=10), were analyzed regarding suicidal behaviour
during the index episode and regarding the suicide attempts during the 6-month follow-up.
Again, the three patients who died were excluded from this drop-out analysis. The patients
who (N=163) completed the follow-up study differed from patients who (N=10) were included
in the 6- but not the 18-month follow-up, in terms of suicide attempts during the index
episode (17% [28/163] vs. 50% [5/10]; χ2=4.6, p=0.03), but not in suicide attempts before the
index episode (44% [72/163] vs. 50% [5/10]; p=1.0), or suicide attempts during the
6-month-follow-up (14% [22/163] vs. 30% [3/10]; p=0.3). Thus, higher rate of attrition of
previously suicidal patients was evident between the 6-month and the 18-month follow-up.
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6.4.1 Follow-up procedure regarding suicidal behaviour
Information on suicide attempts was obtained for 176/191 patients (92%) at the 6-month
follow-up and for 163/191 patients (85%) at the 18-month follow-up. Information about the
occurrence of a suicide attempt during the follow-up was based on both the interview and
the psychiatric and somatic records. Suicide attempt is defined as a self-injurious
behaviour with a nonfatal outcome accompanied by evidence (either explicit or implicit)
that the person intended to die (O’Carroll et al., 1996; APA, 2003); self-harm with no
suicidal intention was not included. An aborted suicide attempt refers to an event in
which an individual is one step away from attempting suicide but does not complete the
act, and thus incurs no physical injury (Barber et al., 1998; APA, 2003). By definition,
an aborted suicide attempt had to involve at least some degree of intent to die, a change
of mind immediately before the actual attempt and the absence of injury. Since nonfatal
suicidal behaviour was one of the main foci of the study, the suicidal behaviour of the
patients was very carefully evaluated. Ten questions about suicidal behaviour at the
6-month follow-up, and 12 questions about suicidal behaviour at the 18-month follow-up
were included in follow-up interviews. Patients were asked about aborted suicide attempts,
suicide attempts with intention to die which were not communicated with professional
staff, about suicide attempts which did not lead to contact to an emergency room, about
timing of suicide attempts, the lethality of suicide attempts and questions of suicidal
behaviour of relatives.
6.5 Statistical methods
The chi-square test with Yates’ correction was used to evaluate categorical and
non-parametric data, the Mann-Whitney, or Kruskal-Wallis, test to compare continuous
variables not normally distributed and the two-sample t-test and One-Way Analysis of
Variance (ANOVA) for continuous variables normally distributed. ANOVA post-hoc
subgroup differences were tested using Tukey’s Honestly Significant Difference test (HSD).
Logistic regression models were used to adjust for confounding factors. Furthermore,
multivariate nominal regression models were created, and suicidal behaviour, as the
dependent variable, was classified into three mutually exclusive categories: non-suicidal
patients (reference group), suicidal ideators without suicide attempts and suicide
attempters. To avoid circularity, the suicidality items of the depression rating scale
were omitted. The Poisson regression model was used to investigate univariate Relative
Risks (RR). The Cox’s proportional hazards regression model with individual frailty was
used to investigate the relative importance of individual risk factors of attempted
suicide. For continuous variables (age, HAMD, and BHS) hazard ratios (HR) were calculated
for increment of 10 units. SPSS software version 11.5 was used.
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7. RESULTS
7.1 Suicidal ideation and attempts in bipolar I and II disorders
(study I)
7.1.1 Clinical and demographic characteristics of the sample
The  characteristics  of  patients  without  suicidal  behaviour, with suicidal ideation, or with
suicide attempts during the index episode are presented in Table 7. Significant
differences were found between the three groups in quality of affective state; severity of
current episode (HAM-D, BDI scores); intensity of suicidal ideation; prevalence of rapid
cycling; personality, anxiety and eating disorders; degree of anxiety and hopelessness and
age at onset. In post-hoc subgroup comparisons, patients with current suicide attempts had
a greater prevalence of comorbid personality disorder (p<0.001) and cluster C disorders
(p<0.001), had more previous suicide attempts (p=0.04) and more suicidal ideation,
according to SSI (p=0.02), than patients with suicidal ideation alone. Specifically,
several item scores were higher among the suicide attempters, these included (item 8)
attitude toward ideation (attempters [median 1.0] vs. ideators [median 1.0]; Z=-2.0,
p=0.04), (item 9) control over suicidal action (attempters [median 1.0] vs. ideators
[median 0.0]; Z=-2.2, p=0.03) and (item 17) suicidal note (attempters [median 0.0] vs.
ideators [median 0.0]; Z=-2.2, p=0.03). There were no significant differences between
patients with suicide attempts and suicidal ideation in severity of depression, measured
by HAM-D, or hopelessness. Patients with suicidal ideation had significantly higher levels
of depression (HAM-D p<0.05; BDI p<0.05), hopelessness (p<0.05), anxiety (p<0.05), fewer
symptoms of mania (YMRS p<0.05), longer duration of last episode (p<0.05) and greater
prevalence of comorbid anxiety disorders (p=0.003) than non-suicidal patients.
7.1.2 Suicidal ideation and attempts during the index episode
Overall, 116 (61%) of the 191 patients reported suicidal ideation during the index episode
(66 females [65%] vs. 50 males [56%]; χ2=1.5, df=1, p=0.20). During the index episode 39
(20%) of the patients had attempted suicide, females more often than males (27 [27%] vs.
12 [13%]; χ2=4.5, df=1, p=0.04). Of those who attempted suicide, 36% (14/39) were referred
to an emergency room and 33% (13/39) were hospitalised; the majority (11/13) were followed
up for less than 24 hours at hospital. Most (30 [77%]) suicide attempters used non-violent
methods. Of patients (N=77) with suicidal ideation alone (no suicide attempt) during the
index episode, in the majority (N=47, 61%), it occurred during a depressive phase and in
23 (30%) during a mixed phase of illness.
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Table 7. Characteristics of 191 Patients with Bipolar Disorder According to Suicidal Behaviours
Non-        Suicidal        Suicide
Suicidal    Ideation       Attempters
                                                     (No attempt)
                                         N=75        N=77            N=39    
   N (%)       N (%)           N (%)   χ2  p
Bipolar disorder I/II
  I                                      40(53)      36(47)          14(36)
  II                                     35(47)      41(53)          25(64)
Gender
  Male                                   40(53)      38(49)          12(31)
  Female                                 35(47)      39(51)          27(69)
Age, mean ± SD, y                        38.7±12.8   38.7±11.5       33.7±11.9
Last episode                                                                         47.6         <0.001
Monophasic episode                       47(63)      36(47)          10(26)          14.7           0.001
  Major depressive phase                 15(20)      22(29)           5(13)
  Manic phase                            18(24)        2(3)            0
  Hypomanic phase                        10(13)        1(1)            0
  Mixed phase (Depressive and manic)       1(1)        4(5)            2(5)
  Mixed phase (Depressive and hypomanic)   3(4)        7(9)            3(8)
Polyphasic episode                       28(37)      41(53)          29(74)          14.7           0.001
Rapid cycling                            16(21)      27(35)          19(49)           9.2           0.01
Current psychotic features               13(17)      13(17)           5(13)
Duration of Last Episode, mean ± SD, ya  0.6±1.3     1.8±3.0         1.5±2.6         16.2         <0.001
Duration of illness, mean ± SD, y      13.3±10.7 15.4±10.7 12.5±9.0
Previous suicide attempts, N (%)         25(33)      34(44)          26(67)          11.7           0.003
Previous suicidal ideation, N (%)        36(48)      60(78)          34(87)          24.3         <0.001
Early age at onset                       15(20)      27(35)          16(41)           6.9           0.03
BDI score, mean ± SDb,c      14.9±9.6  25.1±8.9  25.3±11.5 F=24.0 <0.001
BAI score, mean ± SDb                    17.6±11.9   25.3±10.8       26.7±14.7       F=9.9        <0.001
HAM-D score, mean ± SDb,d                13.8±6.6    19.3±6.2        18.7±7.6        F=13.8       <0.001
YMRS score, mean ± SD                    9.9±11.2    5.9±6.5         5.4±5.9
BHS score, mean ± SDb                    7.4±4.3     11.1±4.7        11.8±5.4        F=14.8       <0.001
SSI score, mean ± SDa                    0.6±1.3     9.2±7.4         13.2±9.6        72.7         <0.001
PSSS-R score, mean ± SD                  43.9±11.7   40.4±13.1       41.1±12.2
SOFAS score, mean ± SD                   50.8±13.1   47.1±10.3       48.0±13.5
Anxiety disorder/ any current            21(28)      40(52)          24(62)          14.9           0.001
Eating disorder/ any current               2(3)        7(9)            6(15)           6.3           0.04
Alcohol dependence/ abuse current        13(17)      13(17)           7(18)
Personality disorder                     24(32)      29(38)          29(74)          20.5         <0.001
Smokinge      35(47)  42(56) 20(54)
a    Kruskal-Wallis test
b    ANOVA = analysis of variance
c    BDI items 2 and 9 are omitted
d    HAM-D item 3 is omitted
e    missing information 4/191; 2%
                        (before 18 years of age)
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7.1.3 Suicidal behaviour before index episode
Only  39 of  191 (20%)  patients  reported no  suicidal behaviour during their lifetime. Either
during the index or preceding episodes, 147 patients (77%) had had suicidal ideation, or
98 patients (51%) had attempted suicide. Before the index episode 130 patients (68 %) had
had serious suicidal ideation, mainly (114; 88%) during a previous depressive episode. Of
the 85 patients (45%) with attempted suicide before the index episode, the majority (66;
78%) had occurred during a depressive episode, eight (9%) during a mixed episode and six
(7%) between illness episodes. The total lifetime number of suicide attempts was one in 34
(18%), two in 23 (12%) and three or more in 41 (21%) of cases.
7.1.4 Prevalence of suicidal behaviour in bipolar I and bipolar II disorders
There were no statistically significant differences in the prevalence of suicidal
behaviour - attempts or ideation - between bipolar I and bipolar II patients before or
during the index episode. Moreover, there were no significant differences between bipolar
I and bipolar II patients regarding the number of suicide attempts. Bipolar II patients
had higher levels of hopelessness (bipolar I patients [mean 9.0±4.9] vs. bipolar II
patients [mean 10.5±5.1]; t=-2.1, df=177, p=0.04). There were no significant differences
with regard to endorsed items on the SSI between bipolar I and II disorders.
7.1.5 Risk factors for suicidal ideation and suicide attempts
The nominal regression models predicting various types of suicidal behaviour during the
index episode are presented in Table 8. The factors most strongly independently associated
with suicidal ideation were severe depressive episode and hopelessness. Suicide attempt
was associated with hopelessness, comorbid personality disorder and a previous suicide
attempt. Since a previous suicide attempt is not a plausible causal risk factor for
current suicide attempt, this was omitted from an alternative model. This had no effect on
the significance of the remaining risk factors; no new variable emerged as significant.
7.2 Suicidal behaviour during different phases of bipolar
disorder (study II)
7.2.1 Prevalence of suicidal behaviour during different phases
There were no suicide attempts during hypomanic/manic phases, whereas suicide attempts
took place during depressive, mixed and depressive mixed phases. Furthermore, there were
marked differences regarding level of suicidal ideation during different phases, with the
highest levels during the mixed phases of the illness (Table 9).
60
7.2.2 Risk factors of suicidal behaviour during different phases
During the depressive phase of BD, severity of current phase (BDI score), Axis II
comorbidity, cluster C comorbidity and previous suicide attempts were related to suicidal
behaviour, whereas hopelessness independently predicted suicide attempts and suicidal
ideation. During the hypomanic/manic phase there were no suicide attempts, whereas any
current anxiety disorder, Axis II comorbidity and cluster B comorbidity, were associated
with suicidal ideation in the relatively rare instances when this occurred. A subjective
rating of severity of depression (BDI) and younger age predicted suicide attempts during
mixed phases (Table 10). Interactions between risk factors did not reach statistical
significance.
Table 8. Nominal Regression Models for Different Suicidal Behaviours
Variable                  Non-  Suicidal Ideation  Suicide Attempt 
suicidal
                          ORa   OR  95% CI   Wald   p   OR 95% CI  Wald   p
Female                    1.0         0.81  0.39 to 1.68  0.32  0.57   0.50  0.19 to 1.28  2.10   0.15
Age, y                    1.0         1.00  0.97 to 1.03  0.10  0.75   1.00  0.94 to 1.02  1.29   0.26
HAM-D score               1.0         1.10  1.04 to 1.17 11.01  0.001  1.05  0.97 to 1.13  1.59   0.21
BHS score                 1.0         1.12  1.04 to 1.22  7.94  0.005  1.16  1.04 to 1.28  7.75   0.005
Previous suicide attempt  1.0         1.40  0.67 to 2.93  0.79  0.38   3.35  1.09 to 7.58  6.40   0.01
Personality Disorder      1.0         0.80  0.37 to 1.72  0.33  0.56   2.99  1.14 to 7.86  4.58   0.03
Subpopulation of BD I
Female                    1.0         2.76  0.80 to 9.60  2.56  0.11   0.84  0.17 to 4.27  0.04   0.84
Age, y                    1.0         0.98  0.93 to 1.04  0.41  0.52   0.99  0.92 to 1.06  0.17   0.68
HAM-D score               1.0         1.17  1.05 to 1.31  8.20  0.004  1.13  0.98 to 1.30  2.78   0.10
BHS score                 1.0         1.20  1.03 to 1.40  5.52  0.02   1.31  1.08 to 1.60  7.56   0.006
Previous Suicide Attempt  1.0         2.55  0.76 to 8.51  2.31  0.13   5.44  1.10 to 26.85 4.32   0.04
Subpopulation of BDII
Female                    1.0         0.43  0.17 to 1.13  2.90  0.09   0.42  0.13 to 1.37  2.07   0.15
Age, y                    1.0         1.00  0.96 to 1.04  0.01  0.92   0.98  0.94 to 1.04  0.38   0.54
HAM-D score               1.0         1.08  1.00 to 1.15  4.33  0.04   1.04  0.96 to 1.13  0.79   0.38
Personality Disorder      1.0         1.06  0.37 to 3.04  0.01  0.92   7.85  2.18 to 28.21 9.96   0.002
a   Reference group
HAM-D = Hamilton Rating Scale; item 3 is omitted
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Table 9. Prevalence of suicidal behaviour during different phases
 Suicide attempts, N (%)a SSI Percentilesb
                                                          25th    50th    75th   
Current Phase Depression (N=105)c 24(23)           0.0     5.0    14.5
Current Phase Depressive Mixed (N=24)d    5 (21) 0.0      6.5 12.8
Current Phase  Mixed  (N=15)              3 (20) 0.0  12.0 17.0
Current Phase Hypomanic/Manic (N=33)      0  0.0  0.0  0.0
a χ2=9.1, df = 3, p=0.03
b    (Kruskal-Wallis test) χ2=20.0, df = 3, p<0.001
c    Post-hoc comparisons between depressive and mixed phase Z=-3.9, p<0.001
     Post-hoc comparisons between depressive and depressive mixed phase Z=-4.0, p<0.001
     Post-hoc comparisons between depressive and hypomanic/manic phase Z=-4.4, p<0.001
d    Post-hoc comparisons between mixed and depressive mixed phase Z=-2.4, p=0.02
Table 10. Multinomial Regression Model for Different Suicidal Behaviours during Different Phases
Variable                  Non-  Suicidal Ideation  Suicide Attempt 
suicidal
                          ORa   OR  95% CI   Wald   p   OR 95% CI  Wald   p
During Depressive Phase
Male                      1.0         0.70  0.27 to 1.82  0.53  0.47   0.36  0.12 to 1.10  3.24   0.07
Age, y                    1.0         1.00  0.95 to 1.02  0.68  0.41   0.99  0.95 to 1.04  0.18   0.67
BHS score                 1.0         1.18  1.05 to 1.32  7.22  0.007  1.16  1.01 to 1.32  4.70   0.03
During Mixed Phases
Male                      1.0         1.61  0.30 to 8.71  0.31  0.58   2.45  0.11 to 56.51 0.31   0.58
Age, y                    1.0         0.94  0.87 to 1.03  1.67  0.20   0.81  0.67 to 0.97  5.09   0.02
BDI score                 1.0         1.16  1.00 to 1.35  3.91  0.05   1.30  1.06 to 1.59  6.44   0.01
a   Reference group
BDI = Beck Depression Inventory (items 2 and 9 omitted)
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7.3 Prospective study of risk factors for attempted suicide among
bipolar disorder patients (study III)
7.3.1 Suicide attempts during the follow-up
At  some  point  during  the  follow-up,  20% of all  patients  (35/176)  attempted  suicide,  of
whom eventually two (1%) died by suicide between the 6- and the 18-month follow-ups. Of
those who attempted suicide, two thirds 69% (24/35) were referred to an emergency room. Of
the suicide attempters not referred to an emergency room, almost half 45% (5/11) had not
communicated with mental health professionals about their suicide attempts. Three patients
(2%) had only aborted suicide attempts during the follow-up. There were no statistically
significant differences in the prevalence of suicide attempters between bipolar I and
bipolar II patients during the 6-month or the 18-month follow-up.
7.3.2 Differences between suicide attempters and non-attempters during
6-month follow-up
During the 6-month follow-up 15% of patients (27/176) attempted suicide, with overdose
being the most commonly used method (21/27 [78%]). During the 6-month follow-up 6% of
patients (11/176) made aborted suicide attempts; three of those who had an aborted suicide
attempt had made no suicide attempts during the 6-month follow-up. The characteristics of
the patients with and without suicide attempts during the 6-month follow-up are presented
in Table 11. Significant differences were found between attempters and non-attempters in
terms of severity of index episode, depression (objective and subjective ratings), amount
of suicidal ideation, amount of anxiety, hopelessness, prevalence of comorbid personality
disorder and prevalence of previous suicide attempts. Suicide attempters were also
associated with early age at first mood episode, fewer episodes of bipolar disorder,
female gender, depressive phase at index episode and younger age at intake.
7.3.3 Differences between suicide attempters and non-attempters during
18-month follow-up
During the 18-month follow-up 18% of patients (29/160) attempted suicide, most (21/29
[72%]) with overdose. Of the 27 patients who had attempted suicide between the baseline
and the 6-month follow-up, two patients (7%) completed suicide, and seven (26%) made
another attempt before the 18-month follow-up. Eight patients who had not attempted
suicide between the baseline and the 6-month follow-up attempted suicide between the 6-
and 18-months follow up. Two percent of patients (3/160) made aborted suicide attempts.
Two of those with an aborted suicide attempt had no previous suicide attempts. The
characteristics of patients with and without suicide attempts during the 18-month
follow-up are presented in Table 12. Significant differences were found between attempters
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and non-attempters in terms of severity of index episode, depression (objective and
subjective ratings), amount of suicidal ideation, amount of anxiety, hopelessness,
prevalence of comorbid personality disorder and prevalence of previous suicide attempts.
Suicide attempters were also associated with fewer episodes of BD, shorter duration of BD,
female gender and younger age at intake.
7.3.4 Predictors of suicide attempts during follow-up
The Cox’s regression model for predicting suicide attempts during follow-up is presented
in Table 13. The factors most strongly independently associated with suicide attempts
during follow-up were: baseline previous suicide attempts, hopelessness, depressive phase
at index episode and younger age at intake. Since a previous suicide attempt is not a
plausible causal risk factor for a current suicide attempt, it was omitted from an
alternative model. This had, however, little effect on the significance of the remaining
risk factors; depressive phase at index episode lost significance, but no new variable
emerged as significant.
7.4 Differences in incidence of suicide attempts during phases of
bipolar I and II disorders (study IV)
7.4.1 Incidence of suicide attempts
During the follow-up, 20% of patients (35/176) reported at least one suicide attempt, and
altogether there were 53 suicide attempts which all could be timed. There were no suicide
attempts during manic/hypomanic phases, nor during euthymic phases. Of the 53 suicide
attempts, 39 (74%) occurred during a major depressive phase, seven (13%) during depressive
mixed phase, three (6%) during mixed phase and four (7%) during depressive symptoms
(Figure 2). Of the 176 patients included in the 6-month follow-up, 3 patients (2%) died
between the 6-month and the 18-month follow-up (2 [1%] by suicide), and 10 patients
dropped out. During the 18-month follow-up; the mean following time was 1.6 person-years.
The incidence of suicide attempts was higher among bipolar II than bipolar I patients in
depressive phase (0.5 vs. 0.3; respectively 27 suicide attempts/56.55 person-years vs. 12
suicide attempts/36.06 person years) and in combined mixed phases (mixed and depressive
mixed) (1.1 vs. 0.6 respectively 7 suicide attempts/6.66 person-years vs. 3 suicide
attempts/4.77 person-years). Bipolar II patients spent more time in risk phases than
bipolar I patients. No interaction was found between these factors.
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Table 11. Baseline characteristics of 176 bipolar disorder patients with and without suicide attempts 
during a 6-month follow-up 
Suicide     Non-            Total   
Attempters Attempters
                                         N=27        N=149           N=176   
   N (%)       N (%)           N (%)   χ2  p
Sociodemographic features
Bipolar disorder I/II
  I                                      11(41)      70(47)          81(46)
  II                                     16(59)      79(53)          95(54)
Gender                                                                               5.4           0.02
  Male                                     7(26)     78(52)          85(48)
  Female                                 20(74)      71(48)          91(52)
Married or cohabiting                    12(44)      62(42)          74(42)
Age, mean ± SD, ya                       32.1±11.2   38.9±12.0       37.9±12.1       t=2.7         0.007
PSSS-R score, mean ± SD                  40.4±12.2   42.6±12.4       42.2±12.4
History of suicidal behaviour
Suicide attempt before/during index      22(82)      67(45)          89(51)          10.8           0.001                                                        episode
Suicide attempt during index episode     13(48)      21(14)          34(19)          14.9         <0.001
Suicide attempt before index episode     19(70)      60(40)          79(45)           7.2           0.007
First degree relative who completed       1(6)     7(6)      8(6)                                                        suicideb
First degree relative who attempted        4(21)      18(15)          22(16)                                                        suicideb
Symptom scores 
BDI score, mean ± SDa,c                  27.2±9.3    19.8±10.7       21.0±10.8       t=-3.3         0.001
BAI score, mean ± SDa                    30.2±12.8 21.4±12.5  22.8±12.9 t=-3.3 0.001
HAM-D score, mean ± SDa,d                20.8±5.2    16.2±7.2        16.9±7.1        t=-3.1         0.002
YMRS score, mean ± SD                    6.4±6.2     7.7±9.3         7.5±8.9
BHS score, mean ± SDa                    14.0±4.1 9.1±4.8    9.8±5.0  t=-4.8   <0.001
SSI score, mean ± SDe                    14.5±9.3    5.3±7.1         6.7±8.2         Z=-4.8       <0.001
SOFAS score, mean ± SD                   45.7±14.0   48.9±11.9       48.4±12.2
Psychiatric comorbidity
Anxiety disorder / any lifetime          18(67)       77(52)          95(54)
Eating disorder / any lifetime             5(19)      21(14)          26(15)
Psychotic features / lifetime            15(56)       72(48)          87(49)
Alcohol dependence / abuse lifetime        9(33)      75(50)          84(48)
Smokingf                                 13(50)       74(50)   87(50)
Personality disorder                     20(74)       59(40)          79(45)         9.6           0.002
   Cluster A                               7(26)      12(8)           19(11)         5.8           0.02
   Cluster B                             12(44)       39(26)          51(29)
   Cluster C                             13(48)       31(21)          44(25)         7.7           0.005
Course of illness
Last phase                                                                     10.9    0.03
   Major depressive phase                17(63)       80(54)          97(55)
   Manic phase                             0          22(15)          22(13)
   Hypomanic phase                         0          18(12)          18(10)
   Mixed phase (Depressive and manic)      3(11)      10(7)           13(7)
   Mixed phase (Depressive and hypomanic)   7(26)      19(13)          26(15)
Polyphasic episode                        15(56)      75(50)          90(51)
Rapid cycling                             10(37)      43(29)          53(30)
Early age at onset (before 18 years of    14(52)      40(27)          54(31)    5.6       0.02                                                        age)
Total number of mood episodes, mean ± SDe  4.6±3.4     10.0±23.0  8.9±20.8 Z=-2.1   0.03
Duration of illness, mean ± SD, y         10.7±7.4    14.8±10.9       14.2±10.5
Adequate pharmacotherapy for the index    13(48)      63(42)          76(43)                                                                phase
a    Student’s t-test
b    23% missing information
c    BDI items 2 and 9 are omitted
d    HAM-D item 3 is omitted
e    Mann-Whitney test
f    2 % missing information
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Table 12. Baseline characteristics of 160 bipolar disorder patients with and without suicide attempts 
during an 18-month follow-up 
Suicide     Non-            Total   
Attempters Attempters
                                         N=29        N=131           N=160   
   N (%)       N (%)           N (%)   χ2  p
Sociodemographic features
Bipolar disorder I/II
  I                                      11(38)      64(49)          75(47)
  II                                     18(62)      67(51)          85(53)
Gender                                                                               4.2           0.04
  Male                                     9(31)     71(54)          80(50)
  Female                                 20(69)      60(46)          80(50)
Married or cohabiting                    13(45)      54(41)          67(42)
Age, mean ± SD, ya                       32.6±10.1   39.9±11.7       38.6±11.8       t=3.1         0.002
PSSS-R score, mean ± SD                  40.4±12.4   42.7±12.2       42.3±12.3
History of suicidal behaviour
Suicide attempt before/during index
episode or during 6-month follow-up      26(90)      55(42)          81(51)          19.7         <0.001
Suicide attempt during index episode     11(38)      16(12)          27(17)           9.4           0.002
Suicide attempt before index episode     19(66)      50(38)          69(43)           6.2           0.01
First degree relative who completed       1(4)     7(6)      8(6)                                                        suicideb
First degree relative who attempted        6(22)      16(15)          22(16)                                                        suicideb
Symptom scores 
BDI score, mean ± SDa,c                  26.4±9.7    19.2±10.7       20.5±10.9       t=-3.3         0.001
BAI score, mean ± SDa                    29.8±13.1 20.7±12.0  22.3±12.7 t=-3.6 <0.001
HAM-D score, mean ± SDa,d                20.7±6.9    16.0±7.1        16.8±7.3        t=-3.2         0.002
YMRS score, mean ± SD                    6.0±5.2     8.0±9.7         7.7±9.1
BHS score, mean ± SDa                    13.3±4.4 8.7±4.9    9.5±5.1  t=-4.6   <0.001
SSI score, mean ± SDe                    13.1±9.5    4.6±6.6         6.2±7.9         Z=-4.7       <0.001
SOFAS score, mean ± SD                   46.0±14.4   48.8±12.1       48.3±12.5
Psychiatric comorbidity
Anxiety disorder / any lifetime          20(69)       65(50)          85(53)
Eating disorder / any lifetime             7(24)      16(12)          23(14)
Psychotic features / lifetime            14(48)       65(50)          79(49)
Alcohol dependence / abuse lifetime      13(45)       65(50)          78(49)
Smokingf                                 13(46)       67(52)   80(51)
Personality disorder                     19(66)       48(37)          67(42)         7.0           0.008
   Cluster A                               7(24)      11(8)           18(11)         4.4           0.04
   Cluster B                             12(41)       29(22)          41(26)
   Cluster C                             11(38)       30(23)          41(26)         7.7           0.005
Course of illness
Last phase during index episode                                                      10.9          0.03
   Major depressive phase                20(69)       67(51)          87(54)
   Manic phase                             0          21(16)          21(13)
   Hypomanic phase                         1(3)       16(12)          17(11)
   Mixed phase (Depressive and manic)      3(10)      10(8)           13(8)
   Mixed phase (Depressive and hypomanic)   5(17)      17(13)          22(14)
Polyphasic episode                        18(62)      62(47)          80(50)
Rapid cycling                             13(45)      34(26)          47(29)
Early age at onset (before 18 years of    13(45)      33(25)          46(29)                                                           age)
Total number of mood episodes, mean ± SDe  4.3±3.5     10.4±23.8  9.3±21.8 Z=-2.7   0.007
Duration of illness, mean ± SD, y         10.9±7.8    15.5±11.0       14.7±10.6      t=2.1         0.03
Adequate pharmacotherapy for the index    10(35)      58(44)          68(43)                                                                phase
a    Student’s t-test
b    15% missing information
c    BDI items 2 and 9 are omitted
d    HAM-D item 3 is omitted
e    Mann-Whitney test
f    1 % missing information
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Table 13. Cox’s regression model for predicting suicide attempters during follow-up
Variable  Suicide Attempt
  OR  95% CI Wald   p   
Bipolar I disorder                       1.20     0.58 to 2.47     0.24    0.62
Male                                     1.52     0.72 to 3.18     1.20    0.27
Age, y                                   0.94     0.91 to 0.97    12.45  <0.001
BHS score                                1.19     1.10 to 1.29    17.30  <0.001
Previous suicide attempts                3.85     1.69 to 8.78    10.27    0.001
Depressive phase at the index episode    2.43     1.11 to 5.35     4.89    0.027
7.4.2  Factors  associated  with  high  incidence  of  suicide  attempts  during
follow-up
The incidence  of  suicide attempts  was  higher among  females  than males and also among
bipolar II than bipolar I patients (Table 14). However, when other risk factors were taken
into account, subtype of bipolar disorder nor gender independently predicted suicide
attempts. Lifetime comorbid anxiety disorders and comorbid personality disorders were
related to a higher incidence of suicide attempts, whereas lifetime comorbid substance
abuse/dependence was not. None of these comorbidities independently predicted suicide
attempts. The higher the values of Hamilton Rating Scale for Depression, as well as Beck
Hopelessness Scale, the higher were the risk ratios of incidence of suicide attempts.
The incidence of suicide attempt was 37-fold during combined mixed and depressive mixed
states and 18-fold during major depressive phase as compared with the other phases (mania,
hypomania, hypomanic symptoms, euthymia, depressive symptoms, cyclothymia and
substance induced phase). The Cox’s proportional hazard model predicting suicide attempts
during follow-up, the predetermined covariates comprised of gender, age, subtype of
bipolar disorder, lifetime comorbid substance dependence/abuse, lifetime any comorbid
anxiety disorder, suicide attempts before follow-up, comorbid personality disorders,
lifetime psychotic features, the highest value of Beck Hopelessness Scale, the highest
value of Hamilton Rating Scale for Depression and the time spent in risk phases, both in
combined mixed phases (mixed and depressive mixed) and depressive phases. In this model
suicide attempts before follow-up increased the risk almost 4-fold, whereas the major
depressive phase increased the risk 11-fold and combined mixed phases (mixed and
depressive mixed) increased the risk almost 28-fold (Figure 3). No interaction between
either of the high-risk phases and the static risk factors modifying the effect was
detected, i.e. there was no evidence for any of the static risk factors modifying the
effect of the high-risk phases.
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Figure 2. Incidence per one year with 95% confidence interval of suicide attempt in
respect to phases of bipolar disorder
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Figure 3. Risk factors of suicide attempts. Hazard ratios with 95% confidence interval
based on multivariate Cox’s proportional hazards model (logarithmic x-axis scale)
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Table 14. Risk factors for suicide attempts. Relative risk (RR) from univariate Poisson 
model, and hazard ratio (HR) from multivariate Cox’s model.
                  Number of     Person-
Variable          suicide attempts    years   Incidence    RR     CI  95% HR   CI 95%    
Static variables
Age at baselinea                                                                     0.96   0.92 to 1.00
Gender
Male                      15          137.28      0.11         1.00   1.00 to 1.00
Female   38          139.03      0.27         2.50   1.38 to 4.55   1.27   0.57 to 2.84
Subtype of bipolar disorder
Bipolar I                 16          129.47      0.12         1.00   1.00 to 1.00
Bipolar II                37          146.84      0.25         2.04   1.13 to 3.67   1.32   0.58 to 3.02
Suicide attempt before follow-up
No                         9          141.05      0.06         1.00   1.00 to 1.00
Yes                       44          135.25      0.33         5.10   2.49 to 10.44  3.98   1.60 to 9.90
Lifetime comorbid substance dependence/abuse
No                        29          140.08      0.21         1.00   1.00 to 1.00
Yes                       24          136.23      0.18         0.85   0.50 to 1.46   0.90   0.42 to 1.93
Any lifetime comorbid anxiety disorder 
No                        16          128.32      0.12         1.00   1.00 to 1.00
Yes                       37          147.99      0.25         2.01   1.12 to 3.60   0.46   0.20 to 1.05
Comorbid personality disorder
No                        18          160.15      0.11         1.00   1.00 to 1.00
Yes                       35          116.16      0.30         2.68   1.52 to 4.73   0.94   0.42 to 2.11
Lifetime psychotic features
No                        28          140.08      0.20         1.00   1.00 to 1.00
Yes                       25          136.23      0.18         0.92   0.54 to 1.57   0.96   0.47 to 1.94
HAM-D maxa, b     [2-18]  10          125.68      0.08         1.00   1.00 to 1.00
HAM-D maxa, b     [19-23] 14            66.61     0.21         2.64   1.17 to 5.95
HAM-D maxa, b    [24-38] 29            84.03     0.35         4.34   2.11 to 8.90   1.04   0.97 to 1.10
BHS maxa, b, c    [1-9]    5          112.17      0.04         1.00   1.00 to 1.00
BHS maxa, b, c    [10-14] 16            77.53     0.21         4.63   1.70 to 12.64
BHS maxa, b, c  [15-20] 31            85.20     0.36         8.16   3.17 to 21.99  1.08   0.99 to 1.18
Time-varying variables
Time spent in
other phasesd              4          172.29      0.02         1.00   1.00 to 1.00
Time spent in
mixed phasese             10           11.42      0.88        37.73  11.83 to 120.29 27.98  7.89 to 99.20
Time spent in major
depressive phases         39           92.61      0.42        18.14   6.48 to 50.76  11.43  3.85 to 34.01
a    For continuous variables (age, HAM-D, and BHS) HR are calculated for increment of 10 units.
b    HAM-D max is defined as the maximum score of Hamilton Rating Scale for Depression (HAM-D) and BHS max is
     defined as the maximum score of Beck Hopelessness scale (BHS). Both HAM-D and BHS were divided into tertiles.
c    There was one Beck Hopelessness Scale missing.
d    Other phases include manic and hypomanic phases, hypomanic symptoms, euthymic, cyclothymic, substance induced mood phases.
e    Mixed phase include both mixed and depressive mixed phases.
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8. DISCUSSION
8.1 Main findings
The Jorvi Bipolar Study (JoBS) is a prospective, naturalistic cohort study  of  191 secondary-
level care psychiatric out- and inpatients with a new episode of DSM-IV BD. One-fifth of
patients attempted suicide and over half of the patients had suicidal ideation during
index episode. In a cross-sectional study, it was shown that 51% of cohort of patients had
attempted suicide either before or during the index episode. In addition to these
patients, eight subjects with no preceding suicide attempts attempted suicide at some
point during the follow-up. Taken together, more than half of the patients (55%; 103/188)
who were initially included in the study and remain alive have attempted suicide during
their lifetime. Previous studies have not investigated the variation in the incidence of
suicide attempts during different phases of bipolar disorder. The incidence of suicide
attempts varies remarkably depending on the type of illness phase during 18-month
follow-up; it increased 37-fold during mixed phases and 18-fold during major depressive
phase.
At the baseline numerous factors were associated with suicidal behaviour in univariate
analyses. In the multivariate models hopelessness, comorbid personality disorder, severe
depression and a previous suicide attempt, with minor differences between ideation and
attempts, were the main independent risk factors. There were no differences in suicidal
behaviour prevalence between bipolar I and II disorders. However, the risk factors for
suicidal behaviour in bipolar I and II disorders were not identical.
There were no suicide attempts during hypomanic/manic phases of the index episode, whereas
suicide attempts took place during depressive, mixed and depressive mixed phases of the
index episode. The highest levels of suicidal ideation were associated with the mixed
phases of the illness. A subjective rating of severity of depression (BDI) and younger age
predicted suicide attempts during mixed phases, whereas hopelessness was independently
associated with suicidal behaviour during the depressive phase of the index episode.
During an 18-month follow-up one-fifth of patients with BD attempted suicide. However, not
all of these attempts led to an emergency room, and a minority of attempters did not even
communicate them to the attending professionals, which suggests that the problem of
suicidal behaviour and, as a consequence, risk of completed suicide among patients with BD
could often be underestimated. Baseline previous suicide attempts, hopelessness,
depressive phase at index episode and younger age at intake independently predicted
suicide attempts during follow-up, whereas having bipolar I or II, or psychiatric Axis I
or II comorbidity did not predict suicide attempts.
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Incidence of suicide attempts varies remarkably depending on the type of illness phase,
with mixed and depressive phases involving highest risk. However, there were many factors
associated with the elevated incidence of suicide attempts, so time spent in risk phases
both in combined mixed phases (mixed and depressive mixed), depressive phases and suicide
attempt before follow-up were the most robust predictors of suicide attempts during
follow-up.
8.2 Results
8.2.1 Suicidal ideation and attempts in bipolar I and II disorders (study I)
Numerous factors were found to be associated with suicide attempts. Many single risk
factors for attempted suicide have been investigated in previous studies, but a
comprehensive view of risk factors related to suicide attempts in bipolar disorder,
particularly bipolar II, is still emerging. In accordance with previous studies anxiety
disorders (Leverich et al., 2003), personality disorders (Leverich et al., 2003; Vieta et
al., 1999; Ucok et al., 1998), eating disorders (Leverich et al., 2003), severity of
depressive episode (Leverich et al., 2003; Lopez et al., 2001; Oquendo et al., 2000; Ucok
et al., 1998), earlier age at onset (Perlis et al., 2004; Slama et al., 2004; Leverich et
al., 2003; Tsai et al., 1999) and suicidal ideation (Oquendo et al., 2000) were
significant predictors of suicide attempts in univariate analyses. Rapid cycling was
related to suicide attempts in univariate analyses convergent with some (Coryell et al.,
2003; MacKinnon et al., 2003) but not all studies (Serretti et al., 2002; Tsai et al.,
1999; Wu and Dunner, 1993). Females attempted suicide more often than males, unlike in
recent studies (Leverich et al., 2003; Lopez et al., 2001; Oquendo et al., 2000). However,
in multivariate models level of hopelessness, comorbid personality disorder and a history
of preceding suicide attempts were the major independent risk factors for suicide
attempts. Thus, the factors most effectively indicating risk for suicide attempts in
bipolar disorder are not much different from those in unipolar depression.
Contrary to expectations, alcohol or substance abuse or dependence were found to be
unrelated to suicide attempts during the index episode. Comorbid alcohol dependence or
abuse is associated with suicide attempts in many (Tondo et al., 1999; Potash et al.,
2000; Goldberg et al., 2001b; Lopez et al., 2001; Slama et al., 2004), but not all studies
(Galfalvy et al., 2006; Oquendo et al., 2000; Leverich et al., 2003). The literature
regarding alcohol or substance abuse or dependence and its association to suicide attempts
among bipolar patients is conflicting.
Suicidal ideation is highly prevalent in bipolar disorder. Over three-fourths of patients
with BD reported suicidal ideation during their lifetime. All suicide attempters also
reported suicidal ideation: so suicidal ideation appears to be a precondition and a highly
sensitive indicator of risk of suicide attempt. Suicide attempters had a significantly
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higher level of suicidal ideation than the mere ideators, which supports a continuum view
of non-fatal suicidal behaviour. Ideators and attempters are an overlapping population in
a lifetime perspective, as nearly half of those with suicidal ideation during the current
episode had attempted suicide during previous episodes. Furthermore, in psychological
autopsy studies, a significant proportion of suicide victims were found to have died at
their first suicide attempt, but having had communicated about suicidal ideation (Isometsä
et al., 1994). Unexpectedly, despite the higher level of ideation, the overall level of
psychopathology was otherwise not different between the two groups. In univariate analyses
comorbid anxiety disorders were related to suicidal ideation, whereas in contrast to
previous studies psychotic symptoms (Bottlender et al., 2000), past suicide attempts
(Bottlender et al., 2000; Goldberg et al., 1999) and personality disorders (Vieta et al.,
1999) were not associated. However in multivariate models, hopelessness and severity of
depressive episode were independent predictors of suicidal ideation. Thus, suicidal
ideation appears largely a reflection of depressive aspects of the illness, with few other
factors besides hopelessness being important.
8.2.2 Suicidal behaviour during different phases of bipolar disorder (study II)
There are no previous studies on the prevalence of suicidal behaviour (both suicidal
ideation and suicide attempts) during different phases. The highest levels of suicidal
ideation were found during the mixed phases of the illness. There were no suicide attempts
during hypomanic/manic phases, whereas suicide attempts took place during depressive,
mixed and depressive mixed phases. Hopelessness was independently associated with suicidal
behaviour during the depressive phase. A subjective rating of severity of depression (BDI)
and younger age predicted suicide attempts during mixed phases.
During the depressive phase of BD, severity of current phase (BDI score), Axis II
comorbidity, cluster C comorbidity and previous suicide attempts were related to suicidal
behaviour, whereas hopelessness independently predicted suicide attempts and suicidal
ideation. During the hypomanic/manic phase there were no suicide attempts, whereas any
current anxiety disorder, Axis II comorbidity and cluster B comorbidity were associated
with suicidal ideation in the relatively rare instances when this occurred.
Mixed phases of the illness were related to the highest level of suicidal ideation; there
was a clear gradient in mixed states proper involving more high SSI scores than the
depressive mixed, and which, in turn, had a greater number of high scores than the
depressive phases. It is noteworthy that despite the highest levels of anxiety in the
mixed phases, anxiety itself was not a predictor for suicidal behaviour. Also, it appears
that a subjective rating (BDI) rather than an objective rating (HAM-D) of the severity of
depression was related to suicidal behaviour in accordance with a prospective study by
Oquendo and colleagues (2004). During the mixed phases hopelessness, subjective severity
of depression, suicidal ideation before index episode, Axis II comorbidity, comorbid
cluster C were associated with suicidal behaviour, whereas subjective severity of
depression and age independently predicted suicide attempts.
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8.2.3 Prospective study of risk factors for attempted suicide among bipolar
disorder patients (study III)
During the 18-month follow-up 20% of patients attempted suicide. Previous prospective
studies have often investigated mixed patient populations; including subjects with both
unipolar and bipolar affective disorders (Fawcett et al., 1990; Nordström et al., 1995;
Oquendo et al., 2004). These studies have suggested that BD may carry a higher risk for
attempted suicide than major depressive disorder (Chen and Dilsaver, 1996; Bottlender et
al., 2000; Sokero et al., 2005). In the Vantaa Depression Study (Sokero et al., 2005), a
comparable study of unipolar patients, 8% of unipolar major depressive patients attempted
suicide during an 18-month follow-up. Thus, findings are concordant with the view that
patients with BD are at particularly high risk for suicidal behaviour.
The prevalence of suicide attempters during the follow-up (20%) was almost same as in
study by Galfalvy et al. (2006), higher than in three other reports; recent study by
Marangell et al. (2006), one with a mixed population (Oquendo et al., 2004) and one with a
mixed inpatient population (Nordström et al., 1995), but lower than in one study (Coryell
et al., 2003). Findings reveal that while suicide attempts among unselected bipolar
patients are carefully investigated every fifth BD patient attempts suicide during a
medium-term (18-month) follow-up. Many studies may have underestimated suicidal
behaviour among bipolar patients, because previous studies have assessed neither aborted
suicide attempts, nor suicide attempts which, despite intent to die, were not communicated
to professionals.
The risk of suicide attempt was predicted by four independent factors: previous suicide
attempts, hopelessness, depressive phase at index episode and younger age at intake.
Whereas having bipolar I or II, or psychiatric Axis I or II comorbidity did not predict
suicide attempts. Hopelessness, which has been researched widely as a risk factor for
suicide attempts in suicidology in general, has seldom been studied among BD patients
(Fawcett et al., 1990; Oquendo et al., 2004; Galfalvy et al., 2006). Hopelessness
independently predicted suicide attempts in both cross-sectional study and the prospective
study of risk factors for suicide attempters.
The findings regarding alcohol and substance dependence or abuse, smoking and rapid
cycling, by contrast, have been much less consistent in the few previous prospective
studies. These factors were not associated with suicide attempters in the study.
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8.2.4 Differences in incidence of suicide attempts during phases of bipolar I
and II disorders (study IV)
No previous study has investigated the variation in the incidence of suicide attempts
during different phases of bipolar disorder. Incidence of suicide attempts varies
remarkably depending on the type of illness phase; it was 37-fold during mixed phases and
18-fold during major depressive phase. Combined mixed (mixed or depressive mixed) or
depressive phases (with risk not significantly modified by any other factor) and prior
suicide attempts independently predicted suicide attempts. Given a population attributable
fraction of 86%, it is obvious that the risk factors which best independently predicted
suicide attempts were the high-risk phases, not the individual characteristics of the
patient.
The prevalence of suicide attempts between bipolar I and II disorders is a controversial
issue (Lester, 1993; Vieta et al., 1997; Rihmer and Pestality, 1999). Some studies
(Stallone et al., 1980; Bulik et al., 1990; Tondo et al., 1999; Balazs et al., 2003) have
reported higher rates of suicide attempts for bipolar II disorder, whereas the Stanley
Foundation Bipolar Network Study (Leverich et al., 2003) and some other studies (Endicott
et al., 1985; Coryell et al., 1987; Dalton et al., 2003) found no difference. Some studies
(Judd et al., 2003a), but not all (Post et al., 2003; Joffe et al., 2004) have reported
the longitudinal symptomatic course of BD II is more dominated by the depressive phase of
illness. Overall, differences in risk for suicide attempts between bipolar I and II
patients are more likely to be largely a consequence of differences in distribution of
time spent at risk, and thus vary depending on the longitudinal course of illness, not by
type of disorder per se. Spending more time depressed or in the mixed illness phases would
readily explain why bipolar II is often associated with more frequent suicidal behaviour
than bipolar I.
Research on suicidology has shown that time-varying risk factors are important (Kraemer et
al., 1997). Kapur et al. (2006) found in their recent multicentre cohort study that
repetition of suicidal behaviour tended to occur quickly - almost half of individuals who
did so repeated within one year within the first two months after the index episode.
Regarding bipolar patients, Ösby et al. (2001) found standardized mortality ratios to be
especially high during the first years after the first diagnosis. Likewise, Høyer et al.
(2002) reported that the risk of suicide was high immediately after admission and
immediately following discharge among hospitalised affective disorder patients. Even if
these studies have emphasized the importance on time aspects of suicidal behaviour, there
are no previous studies which would take into account any aspect of time spent in
different phases of bipolar disorder, when investigating the risk factors of attempted
suicide.
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8.3 Methods
8.3.1 Sample and diagnostic measures
The Jorvi Bipolar Study (JoBS) is the first clinical cohort study based on systematic
screening for bipolar disorder within a geographically defined catchment area. The study
involved a relatively large (N=191) and unselected sample of both in- and outpatients with
a new phase of bipolar I and II disorder from three Finnish cities (Espoo, Kauniainen,
Kirkkonummi).
Patients entering the study were carefully diagnosed using semi-structured SCID-I
interviews with excellent reliability for diagnosing bipolar I and II disorders (κ=1.0
and 1.0, respectively). Furthermore, both Axis I and Axis II comorbidities were evaluated
and patients’ symptomatic status and other characteristics were assessed, with a number of
standardized observer scales and questionnaires (Mantere et al., 2004).
8.3.2 Life-chart methodology
The graphic life-chart used in this study is similar, but not identical, to the
Longitudinal Interval Follow-Up Evaluation (LIFE) or NIMH life-chart methodology used in
the other prospective studies including and reporting on BD types I and II separately
(Judd et al., 2003b; 2003c; Post et al., 2003; Dittman et al., 2002; Nolen et al., 2004;
Joffe et al., 2004). This kind of graphic life-chart was planned and used in the Vantaa
Depression Study (Melartin et al., 2004). As with the LIFE, change points in the
psychopathologic state using probes related to important events were investigated. Unlike
the LIFE, in the interview the life-chart was made directly comparable with the DSM-IV
criteria, and classified the patients’ follow-up time into periods of 4 DSM-IV phases of
BD (major depression, mania, hypomania, mixed episode) plus depressive mixed states, full
remission with no symptoms of phases and partial remission, when criteria for neither mood
episode nor full symptomatic remission were fulfilled. The life-chart was constructed in
the two follow-up interviews based on patients’ report, all available patient records and
all other information when needed. Time after the baseline interview was divided into 10
time periods: euthymia, manic, hypomanic, major depressive, mixed, depressive mixed
(according to Benazzi and Akiskal, 2001), cyclothymic, substance induced mood phase,
depressive and hypomanic symptoms (Mantere et al., in press).
75
8.3.3 Evaluation of suicidal behaviour
8.3.3.1 Strengths of the evaluation of suicidal behaviour
The present study is also among the few (Oquendo et al., 2000; 2004; Galfalvy et al.,
2006) using a psychometric scale to measure current suicidal ideation, as well as suicidal
ideation during the whole current episode. There are no previous studies on the prevalence
of suicidal behaviour (both suicidal ideation and suicide attempts) during different
phases. Furthermore, previous studies have not assessed the risk factors of the many
domains for attempted suicide during depressive and mixed phases. Previous studies have
not reported the prevalence of suicidal behaviour during the depressive mixed phase
(depressive mixed phase defined according to Benazzi and Akiskal, 2001). Previous studies
have not reported aborted suicide attempts among bipolar patients, nor to actively
investigate suicide attempts that otherwise often remain hidden due to lack of contact
with services or communication with professionals (study III). There are no previous
studies which have examined the differences in incidence during different phases of
bipolar disorder. Moreover, previous studies have not estimated the relative importance of
static vs. time-varying risk factors for overall risk for suicide attempts nor importance
of time at risk for overall risk (study IV). Neither are there studies regarding suicidal
behaviour among bipolar patients which would estimate the population attributable fraction
(study IV).
8.3.3.2 Limitations of evaluation of suicidal behaviour 
Suicidal ideation based on an aggregate variable (either current SSI ≥ 6 or had seriously
considered suicide earlier during the index episode) was reported (study I). However, the
findings were essentially the same when analyses were conducted separately, based on only
the SSI or ideation during the episode. The temporal association between suicidal ideation
and attempts is complex. The fact that suicide attempts could occur at any time during the
whole index episode, but that the symptoms were measured at the time of the first
interview (Mantere et al., 2004), may have caused an underestimation of psychopathology at
the time of attempt (study I). The most important limitation of study II was the small
number of suicide attempters during mixed and depressive mixed phases. Because of multiple
comparisons and small sample sizes, risk of spurious findings may exist in the descriptive
univariate analyses. The multinomial models constitute main findings. Although they are
statistically robust, some degree of type II error may have also occurred (study II).
While this study is among the few prospective studies assessing risk factors for attempted
suicide in persons with BD, patients were only followed for up to 18 months. Fawcett and
co-workers (1990) found that short-term (follow-up of less than one year) predictors of
death by suicide or serious suicide attempts differed from long-term (two to ten years)
predictors. Therefore, a longer follow-up period is likely needed to examine the
differences between short- and long-term predictors for attempted suicide (study III).
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Although 92% and 85% of patients were followed at 6 and 18 months, respectively, there was
a somewhat higher drop-out rate of suicidal patients after the 6-month follow-up visit.
Therefore the single risk factors of suicide attempters among those who were followed up
after 6 and 18 months were analyzed separately. Since the findings remained consistent, it
is unlikely that attrition biased the results with regard to predictors. However, the
possibility of undetected suicide attempters among those dropping out of the follow-up
cannot be excluded (study III). Since the aim was to investigate risk factors predicting
future suicide attempts, the potential preventive effect of maintenance treatment or
longitudinal course of illness on outcome was not examined (study III). One weakness was
that information on lifetime aggression and impulsivity, which were linked to suicidal
behaviour in a recent prospective study by Oquendo and co-workers (2004), was not
gathered. However, aggression and impulsive behaviour are commonly related to comorbid
cluster B personality disorders (Oquendo et al., 2004) and substance or alcohol abuse or
dependence, neither of which independently predicted suicide attempts in prospective study
(study III and study IV). In theory there could be circularity between suicide attempts
and major depressive phase. However, suicidal ideation, not suicide attempt, is one of
nine major depressive phase criteria symptoms (study IV). Only average time spent in risk
phases was investigated. It is possible that the risk of suicide attempts varies more than
could be measured during the separate phase depending on the severity of depression. This
relatively crude classification is, despite observed marked contrast between phases,
unlikely to reveal fully the true variations in risk that likely depend on the severity of
symptoms.
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9. CONCLUSIONS AND FUTURE IMPLICATIONS
9.1 Conclusions and clinical implications
Suicidal behaviour is markedly prevalent among bipolar patients. Over their lifetime, more
than half of the patients with bipolar disorder attempt suicide. Suicidal behaviour varies
markedly between different phases. Furthermore, the incidence of suicide attempts varies
remarkably depending on the type of illness phase, with mixed and depressive phases
involving the highest risk per time. Time spent at high-risk illness phases is most likely
the major determinant of overall risk for suicide attempts among patients with BD.
During the index episode, suicide attempts and suicidal ideation are related to phases
which are associated with depressive aspects of the illness. Hopelessness and severity of
depression are key indicators of risk in all phases. Preceding suicidal behaviour,
hopelessness, depression and comorbidity are all key indicators of risk. Based on the
cross-sectional study, the prevalence of suicidal behaviour in bipolar I and II disorders
are similar, but the risk factors for it may differ somewhat between the two. However,
based on the prospective study it seems that spending more time depressed or in the mixed
illness phases would readily explain why bipolar II is often associated with more frequent
suicidal behaviour than bipolar I.
More than half of the patients have attempted suicide during their lifetime, a finding
which highlights the public health importance of suicidal behaviour in bipolar disorder.
Suicidal behaviour is associated with depressive aspects of illness. Clinically, it is
crucial to recognize BD and manage the mixed and depressive phases of bipolar patients
fast and effectively as time spent in depressive and mixed phases involves a remarkably
high risk of suicide attempts. Reducing time spent in risk phases is probably an important
preventive measure. It is important to evaluate suicidal behaviour of BD patients and try
to prevent it by intensive treatment.
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9.2 Implications for future research
Many single risk factors for suicidal behaviour have been investigated in previous
cross-sectional and retrospective studies, but a comprehensive view of risk factors
related to suicidal behaviour in bipolar disorder is still emerging. Furthermore, there
are only few prospective studies regarding suicidal behaviour in bipolar disorder.
Although hopelessness is an essential risk factor for suicidology overall, it’s role has
been rarely investigated in bipolar disorder. There is a need for prospective studies to
investigate the wide range of risk factors of suicidal behaviour and use of multivariate
statistics, which is needed to differentiate independent risk factors from confounding
associations.
Furthermore, future suicide studies should investigate not only static but also
time-varying risk factors, and include time at risk estimations when estimating overall
suicide risk. Future studies based on daily prospective mood ratings should investigate if
the risk of suicide attempt is identical during the whole phase. Challenges for future
studies will be to investigate whether there are modifying risk factors during different
phases, when more risk factors are taken into account and in a larger sample of bipolar
patients. In addition, future studies should examine the effect of both interventions -
effective acute phase treatment of high-risk phases and effective maintenance treatment to
prevent recurrences of high-risk phases - to prevent suicidal behaviour in bipolar
disorder.
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